<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN" "JATS-journalpublishing1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" dtd-version="1.1" specific-use="sps-1.9" article-type="research-article" xml:lang="pt">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Arq Bras Cardiol</journal-id>
      <journal-id journal-id-type="publisher-id">abc</journal-id>
      <journal-title-group>
        <journal-title>Arquivos Brasileiros de Cardiologia</journal-title>
        <abbrev-journal-title abbrev-type="publisher">Arq. Bras. Cardiol.</abbrev-journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0066-782X</issn>
      <issn pub-type="epub">1678-4170</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Cardiologia - SBC</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id specific-use="scielo-v3" pub-id-type="publisher-id">RxMLWTcN4p5MRpP4DcsfNFH</article-id>
      <article-id specific-use="scielo-v2" pub-id-type="publisher-id">S0066-782X2023000200307</article-id>
      <article-id pub-id-type="other">00307</article-id>
      <article-id pub-id-type="doi">10.36660/abc.20220070</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Artigo Original</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Incid&#234;ncia de Hipertens&#227;o Arterial est&#225; Associada com Adiposidade em Crian&#231;as e Adolescentes</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">0000-0003-1134-2383</contrib-id>
          <name>
            <surname>Welser</surname>
            <given-names>Let&#237;cia</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
          <role>Concep&#231;&#227;o e desenho da pesquisa</role>
          <role>Obten&#231;&#227;o de dados</role>
          <role>An&#225;lise e interpreta&#231;&#227;o dos dados e Reda&#231;&#227;o do manuscrito</role>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Pfeiffer</surname>
            <given-names>Karin Allor</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">
            <sup>2</sup>
          </xref>
          <role>Revis&#227;o cr&#237;tica do manuscrito quanto ao conte&#250;do intelectual importante</role>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Silveira</surname>
            <given-names>Jo&#227;o Francisco de Castro</given-names>
          </name>
          <xref ref-type="aff" rid="aff3">
            <sup>3</sup>
          </xref>
          <role>Obten&#231;&#227;o de dados</role>
          <role>An&#225;lise e interpreta&#231;&#227;o dos dados e Reda&#231;&#227;o do manuscrito</role>
          <role>An&#225;lise estat&#237;stica</role>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Valim</surname>
            <given-names>Andreia Rosane de Moura</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
          <role>Revis&#227;o cr&#237;tica do manuscrito quanto ao conte&#250;do intelectual importante</role>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Renner</surname>
            <given-names>Jane Dagmar Pollo</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
          <role>Revis&#227;o cr&#237;tica do manuscrito quanto ao conte&#250;do intelectual importante</role>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Reuter</surname>
            <given-names>C&#233;zane Priscila</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
          <role>Concep&#231;&#227;o e desenho da pesquisa</role>
          <role>Obten&#231;&#227;o de dados</role>
          <role>An&#225;lise estat&#237;stica Revis&#227;o cr&#237;tica do manuscrito quanto ao conte&#250;do intelectual importante</role>
        </contrib>
      </contrib-group>
      <aff id="aff1">
        <label>1</label>
        <institution content-type="orgname">Universidade de Santa Cruz do Sul</institution>
        <addr-line>
          <named-content content-type="city">Santa Cruz do Sul</named-content>
          <named-content content-type="state">RS</named-content>
        </addr-line>
        <country country="BR">Brasil</country>
        <institution content-type="original"> Universidade de Santa Cruz do Sul, Santa Cruz do Sul, RS &#8211; Brasil</institution>
      </aff>
      <aff id="aff2">
        <label>2</label>
        <institution content-type="orgname">Michigan State University</institution>
        <addr-line>
          <named-content content-type="city">East Lansing</named-content>
          <named-content content-type="state">Michigan</named-content>
        </addr-line>
        <country country="US">EUA</country>
        <institution content-type="original"> Michigan State University, East Lansing, Michigan &#8211; EUA</institution>
      </aff>
      <aff id="aff3">
        <label>3</label>
        <institution content-type="orgname">Universidade Federal do Rio Grande do Sul</institution>
        <addr-line>
          <named-content content-type="city">Porto Alegre</named-content>
          <named-content content-type="state">RS</named-content>
        </addr-line>
        <country country="BR">Brasil</country>
        <institution content-type="original"> Universidade Federal do Rio Grande do Sul, Porto Alegre, RS &#8211; Brasil</institution>
      </aff>
      <author-notes>
        <corresp id="c01"> Correspond&#234;ncia: Let&#237;cia Welser &#8226; Universidade de Santa Cruz do Sul &#8211; Av. Independ&#234;ncia, 2293 Bloco 42, sala 4206. CEP 96815-900, Santa Cruz do Sul, RS &#8211; Brasil. E-mail: <email>leticiawelser2017@gmail.com</email> </corresp>
        <fn fn-type="conflict">
          <p>Potencial conflito de interesse</p>
          <p>N&#227;o h&#225; conflito com o presente artigo</p>
        </fn>
      </author-notes>
      <pub-date date-type="pub" publication-format="electronic">
        <day>06</day>
        <month>03</month>
        <year>2023</year>
      </pub-date>
      <pub-date date-type="collection" publication-format="electronic">
        <month>02</month>
        <year>2023</year>
      </pub-date>
      <volume>120</volume>
      <issue>2</issue>
      <elocation-id>e20220070</elocation-id>
      <history>
        <date date-type="received">
          <day>27</day>
          <month>01</month>
          <year>2022</year>
        </date>
        <date date-type="rev-recd">
          <day>17</day>
          <month>08</month>
          <year>2022</year>
        </date>
        <date date-type="accepted">
          <day>05</day>
          <month>10</month>
          <year>2022</year>
        </date>
      </history>
      <permissions>
        <license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by/4.0/" xml:lang="en">
          <license-p> This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </license-p>
        </license>
      </permissions>
      <abstract>
        <title>Resumo</title>
        <sec>
          <title>Fundamento</title>
          <p> O aumento de hipertens&#227;o em crian&#231;as e adolescentes tem atra&#237;do a aten&#231;&#227;o da comunidade cient&#237;fica, especialmente por sua associa&#231;&#227;o com a epidemia da obesidade.</p>
        </sec>
        <sec>
          <title>Objetivos</title>
          <p> Descrever a incid&#234;ncia de hipertens&#227;o e sua rela&#231;&#227;o com o perfil cardiometab&#243;lico e gen&#233;tico em crian&#231;as e adolescentes de uma cidade do sul do Brasil em um per&#237;odo de tr&#234;s anos.</p>
        </sec>
        <sec>
          <title>M&#233;todos</title>
          <p> Este estudo longitudinal acompanhou 469 crian&#231;as e adolescentes com idade entre 7 e 17 anos (43,1% do sexo masculino), avaliados em dois momentos. Avaliamos press&#227;o arterial sist&#243;lica (PAS), press&#227;o arterial diast&#243;lica (PAD), circunfer&#234;ncia da cintura (CC), &#237;ndice de massa corporal (IMC), porcentagem de gordura corporal (%GC), perfil lip&#237;dico, glicemia, aptid&#227;o cardiorrespirat&#243;ria (APCR), e polimorfismo rs9939609 (gene <italic>FTO</italic> ) ( <italic>fat mass and obesity</italic> - <italic>associated gene</italic> ). A incid&#234;ncia cumulativa da hipertens&#227;o foi calculada, e realizada regress&#227;o log&#237;stica multinominal. A diferen&#231;a estat&#237;stica foi estabelecida em p&lt;0,05.</p>
        </sec>
        <sec>
          <title>Resultados</title>
          <p> Ap&#243;s tr&#234;s anos, a incid&#234;ncia de hipertens&#227;o foi de 11,5%. Indiv&#237;duos com sobrepeso e indiv&#237;duos obesos apresentaram maior probabilidade de se tornarem indiv&#237;duos classificados como <italic>borderline</italic> para hipertens&#227;o (sobrepeso OR: 3,22; IC95%: 1,08-9,55; obesidade OR: 4,05; IC95%: 1,68-9,75), e indiv&#237;duos obesos apresentaram maior probabilidade de se tornarem hipertensos (obesidade OR: 4,84; IC95%: 1,57-14,95). Valores de CC e de %GC considerados de alto risco foram associados com o desenvolvimento de hipertens&#227;o (OR: 3,41; IC95%: 126-9,19; OR: 2,49, IC95%: 1,08-5,75, respectivamente).</p>
        </sec>
        <sec>
          <title>Conclus&#227;o</title>
          <p> Encontramos uma incid&#234;ncia de hipertens&#227;o em crian&#231;as e adolescentes mais alta em compara&#231;&#227;o a estudos anteriores. Indiv&#237;duos com valores mais altos de IMC, CC e %GC no <italic>baseline</italic> apresentaram maior probabilidade de desenvolverem hipertens&#227;o, sugerindo a import&#226;ncia da adiposidade no desenvolvimento de hipertens&#227;o, mesmo em uma popula&#231;&#227;o t&#227;o jovem.</p>
        </sec>
      </abstract>
      <kwd-group xml:lang="pt">
        <kwd>Doen&#231;as Cardiovasculares</kwd>
        <kwd>Press&#227;o Arterial</kwd>
        <kwd>Obesidade</kwd>
      </kwd-group>
      <funding-group>
        <award-group>
          <funding-source>CAPES</funding-source>
          <award-id>001</award-id>
        </award-group>
        <funding-statement>Fontes de financiamento: O presente estudo foi financiado pela CAPES &#8211; C&#243;digo de Financiamento 001. Edital FAPERGS/CAPES 06/2018 - Programa de Internacionaliza&#231;&#227;o da P&#243;s-Gradua&#231;&#227;o.</funding-statement>
      </funding-group>
      <counts>
        <fig-count count="8"/>
        <table-count count="6"/>
        <equation-count count="0"/>
        <ref-count count="55"/>
      </counts>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>Introdu&#231;&#227;o</title>
      <p>O aumento nos n&#237;veis press&#243;ricos ao longo do tempo em crian&#231;as e adolescentes tem atra&#237;do a aten&#231;&#227;o de profissionais da sa&#250;de e da comunidade cient&#237;fica,<sup><xref rid="B1" ref-type="bibr">1</xref></sup> especialmente devido &#224; sua associa&#231;&#227;o com a epidemia da obesidade.<sup><xref rid="B2" ref-type="bibr">2</xref></sup> De acordo com um estudo recente,<sup><xref rid="B3" ref-type="bibr">3</xref></sup> estima-se que a preval&#234;ncia de hipertens&#227;o em crian&#231;as e adolescentes no mundo seja de 4%, e a preval&#234;ncia de press&#227;o arterial elevada, de acordo com as novas diretrizes do <italic>American Academy of Pediatrics</italic> , seja de 15%. Embora essas estimativas de preval&#234;ncia provavelmente tenham sido subestimadas antes da recente reclassifica&#231;&#227;o,<sup><xref rid="B4" ref-type="bibr">4</xref></sup> dados indicam que as taxas nos pa&#237;ses em desenvolvimento estejam aumentando.<sup><xref rid="B5" ref-type="bibr">5</xref></sup></p>
      <p>Nos &#250;ltimos anos tem sida dada maior aten&#231;&#227;o &#224; rela&#231;&#227;o entre hipertens&#227;o e o desenvolvimento de les&#227;o de &#243;rg&#227;o-alvo decorrente de disfun&#231;&#227;o precoce. Os principais fatores de risco modific&#225;veis para prevenir acidente vascular cerebral e outra doen&#231;as s&#227;o hipertens&#227;o,<sup><xref rid="B6" ref-type="bibr">6</xref> , <xref rid="B7" ref-type="bibr">7</xref> </sup> diabetes mellitus, tabagismo, e dislipidemia, bem como m&#225; alimenta&#231;&#227;o/nutri&#231;&#227;o, sedentarismo e obesidade.<sup><xref rid="B8" ref-type="bibr">8</xref></sup> A forte associa&#231;&#227;o entre obesidade e hipertens&#227;o conduziu ao desenvolvimento de v&#225;rias medidas simples, de baixo custo, para avalia&#231;&#227;o de adiposidade corporal, por exemplo, &#237;ndice de massa corporal (IMC), circunfer&#234;ncia da cintura (CC), e porcentagem de gordura corporal (%GC).<sup><xref rid="B9" ref-type="bibr">9</xref></sup> Sabe-se que o risco de hipertens&#227;o aumenta com o aumento dos &#237;ndices de obesidade, elevando as chances de problemas cardiometab&#243;licos.<sup><xref rid="B10" ref-type="bibr">10</xref></sup> Est&#225; bem documentado na literatura que fatores de risco durante a inf&#226;ncia podem levar a complica&#231;&#245;es cardiorrespirat&#243;rias na adolesc&#234;ncia<sup><xref rid="B11" ref-type="bibr">11</xref></sup> e na fase adulta.<sup><xref rid="B12" ref-type="bibr">12</xref></sup></p>
      <p>Outro fator de risco importante para hipertens&#227;o s&#227;o os baixos n&#237;veis de aptid&#227;o cardiorrespirat&#243;ria (APCR). Dados mostram que n&#237;veis mais altos de APCR promovem menor risco de hipertens&#227;o.<sup><xref rid="B13" ref-type="bibr">13</xref></sup> Vari&#225;veis bioqu&#237;micas como dislipidemia,<sup><xref rid="B14" ref-type="bibr">14</xref></sup> hiperuricemia,<sup><xref rid="B15" ref-type="bibr">15</xref></sup> e n&#237;veis alterados de glicemia (resist&#234;ncia &#224; insulina)<sup><xref rid="B16" ref-type="bibr">16</xref></sup>mostraram-se importantes fatores de risco modific&#225;veis para a hipertens&#227;o.</p>
      <p>Embora a hipertens&#227;o tenha sido documentada em v&#225;rios estudos, h&#225; poucos estudos sobre a incid&#234;ncia de hipertens&#227;o na popula&#231;&#227;o geral.<sup><xref rid="B17" ref-type="bibr">17</xref></sup> Estudos abordando a incid&#234;ncia de hipertens&#227;o e sua rela&#231;&#227;o com outras vari&#225;veis cardiometab&#243;licas, incluindo perfil gen&#233;tico, em crian&#231;as e adolescentes s&#227;o ainda mais escassos. Com base nessas considera&#231;&#245;es, o objetivo deste estudo foi descrever a incid&#234;ncia de hipertens&#227;o, sua rela&#231;&#227;o com vari&#225;veis cardiometab&#243;licas e gen&#243;tipos do polimorfismo rs9939609 do gene FTO em crian&#231;as e adolescentes de uma cidade no sul do Brasil.</p>
    </sec>
    <sec sec-type="methods">
      <title>M&#233;todos</title>
      <p>A popula&#231;&#227;o alvo deste estudo de coorte retrospectivo foi crian&#231;as e adolescentes volunt&#225;rios da cidade de Santa Cruz do Sul, RS, Brasil. Todos os procedimentos foram conduzidos em laborat&#243;rios, salas e complexo esportivo do campus universit&#225;rio, e consistiram em avalia&#231;&#227;o de dados de APCR, dados antropom&#233;tricos, bioqu&#237;micos e de polimorfismo gen&#233;tico.</p>
      <p>Os crit&#233;rios de inclus&#227;o para esta subamostra foram estudantes que: a) compareceram &#224;s avalia&#231;&#245;es de 2011 e de 2014; b) participaram da coleta de sangue; c) submeteram-se &#224; avalia&#231;&#227;o antropom&#233;trica completa; d) preencheram todos os formul&#225;rios; e e) tinham idade entre sete e 17 anos em ambas as avalia&#231;&#245;es. No total, resultados de 469 estudantes foram analisados, como apresentado na <xref rid="f01" ref-type="fig">Figura Central</xref> .</p>
      <p>
        <fig id="f01">
          <label>Figura Central</label>
          <caption>
            <title>: Incid&#234;ncia de Hipertens&#227;o Arterial est&#225; Associada com Adiposidade em Crian&#231;as e Adolescentes</title>
          </caption>
          <graphic xlink:href="1678-4170-abc-120-02-e20220070-20070-gf01.tif"/></fig>
      </p>
      <p>Os participantes deste estudo foram crian&#231;as e adolescentes entre sete e 17 anos de idade, de ambos os sexos, de 19 escolas p&#250;blicas e privadas, estratificados por regi&#227;o (norte, sul, leste, oeste e centro), de &#225;reas urbanas e rurais. A amostra escolhida &#233; oriunda de dois bancos de dados, incluindo somente estudantes que compareceram &#224;s avalia&#231;&#245;es f&#237;sicas em 2011/2012 ( <italic>baseline</italic> ) e retornaram em 2014/2015 ( <italic>follow-up</italic> ) ( <xref rid="f02" ref-type="fig">Figura 1</xref> ). Os bancos de dados derivam de um estudo maior chamado &#8220;Sa&#250;de dos Escolares&#8221;, estratificado por grupos. O estudo foi aprovado pelo Comit&#234; de &#201;tica em Pesquisa com Seres Humanos da Universidade de Santa Cruz do Sul - UNISC (n&#250;meros 2959/2011 e 714.216 para o <italic>baseline</italic> e <italic>follow-up</italic> , respectivamente). Todos os pais ou respons&#225;veis foram informados sobre os procedimentos e assinaram um termo de consentimento, autorizando a participa&#231;&#227;o do aluno no estudo.</p>
      <p>
        <fig id="f02">
          <label>Figura 1</label>
          <caption>
            <title>&#8211; Fluxograma de sele&#231;&#227;o da amostra do estudo.</title>
          </caption>
          <graphic xlink:href="1678-4170-abc-120-02-e20220070-20070-gf02.tif"/></fig>
      </p>
      <p>As vari&#225;veis inclu&#237;das no estudo foram press&#227;o arterial sist&#243;lica (PAS), press&#227;o arterial diast&#243;lica (PAD), CC, IMC, %GC, perfil lip&#237;dico &#8211; triglicer&#237;deos (TG), colesterol total (CT), lipoprote&#237;na de alta densidade (HDL-c), lipoprote&#237;na de baixa densidade (LDL-c), glicemia, e APCR.</p>
      <p>A PAS e a PAD foram medidas duas vezes com o estudante sentado por no m&#237;nimo cinco minutos em uma sala quieta. Foram usados um esfigmoman&#244;metro e um estetosc&#243;pio no bra&#231;o direito, e um manguito apropriado para a circunfer&#234;ncia do bra&#231;o. A PAS foi determinada pela detec&#231;&#227;o do primeiro som de Korotkoff e a PAD pelo som na fase 5 dos sons de Korotkoff, isto &#233;, quando os sons n&#227;o s&#227;o mais aud&#237;veis ou quando o timbre do som muda. Essas medidas foram classificadas pelos percentis 90 e 95 para <italic>borderline</italic> e hipertens&#227;o, de acordo com as Diretrizes Pr&#225;ticas para o Rastreamento e Manejo de Hipertens&#227;o em Crian&#231;as e Adolescentes.<sup><xref rid="B18" ref-type="bibr">18</xref></sup></p>
      <p>A medida da CC foi realizada usando uma fita inel&#225;stica (Cardiomed&#174;) com 1 mm de precis&#227;o. As medidas foram tomadas na regi&#227;o mais estreita do tronco entre as costelas e a crista il&#237;aca. A CC foi classificada segundo o proposto por Fern&#225;ndez et al.;<sup><xref rid="B19" ref-type="bibr">19</xref></sup> a obesidade abdominal foi definida por medidas de CC acima do percentil 75 para sexo e idade. Para o c&#225;lculo do IMC, a altura foi medida utilizando um estadi&#244;metro acoplado &#224; balan&#231;a (Filizola&#174;), a qual foi usada para avalia&#231;&#227;o do peso corporal, com os participantes descal&#231;os, vestindo roupas leves. O IMC foi calculado pela f&#243;rmula peso / altura<sup><xref rid="B2" ref-type="bibr">2</xref></sup> (kg/m<sup><xref rid="B2" ref-type="bibr">2</xref></sup>), e os resultados classificados de acordo as curvas de percentis para idade e sexo propostas pela OMS em 2007.<sup><xref rid="B20" ref-type="bibr">20</xref></sup> Participantes com valores no percentil &lt;3 foram classificados em baixo peso, no percentil &#8805;85 como sobrepeso, e no percentil &#8805; 97 como obeso. Para a medida da %GC, foram medidas as pregas tricipital e subescapular usando o adip&#244;metro Lange&#174; (MultiMed, Skinfold Caliper, EUA). O c&#225;lculo da %GC foi realizado pela equa&#231;&#227;o de Heyward e Stolarczyk<sup><xref rid="B21" ref-type="bibr">21</xref></sup> e classificada como muito baixa, baixa, ideal, moderadamente alta, alta, e muito alta de acordo com Lohman.<sup><xref rid="B22" ref-type="bibr">22</xref></sup> As tr&#234;s primeiras categorias foram reclassificadas como n&#237;veis mais baixos e as demais categorias como n&#237;veis mais altos para an&#225;lises.</p>
      <p>Para o perfil lip&#237;dico e a glicemia, 10mL de sangue foram coletados da veia braquial ap&#243;s jejum de 12 horas; 5mL foram colocados em tubos Vacutainer&#174; para an&#225;lise de par&#226;metros cardiometab&#243;licos, e 5mL em tubos contendo EDTA para outras an&#225;lises. N&#237;veis de CT, HDL-c, LDL-c, TG e glicemia foram avaliados em amostras do soro. Os valores de CT, HD-c, LDL-c e TG foram classificados de acordo com valores de refer&#234;ncia internacionais.<sup><xref rid="B23" ref-type="bibr">23</xref></sup> Os participantes foram considerados como dislipid&#234;micos se apresentassem altera&#231;&#227;o em pelo menos um desses par&#226;metros. O LDL-c foi calculado usando a equa&#231;&#227;o de Friedewald.<sup><xref rid="B24" ref-type="bibr">24</xref></sup> Os valores de glicemia foram determinados no laborat&#243;rio de bioqu&#237;mica do exerc&#237;cio da universidade, utilizando o equipamento automatizado Miura One (I.S.E., Roma, It&#225;lia) e o kit comercial DiaSys (DiaSys Diagnostic Systems, Alemanha), e classificados de acordo com os protocolos da <italic>American Diabetes Association</italic>: <sup><xref rid="B25" ref-type="bibr">25</xref></sup> normal, pr&#233;-diabetes e diabetes. Para as an&#225;lises estat&#237;sticas, as classes de pr&#233;-diabetes e diabetes foram agrupadas e consideradas como glicemia elevada.</p>
      <p>Para a avalia&#231;&#227;o do polimorfismo gen&#233;tico rs9939609 do gene associado &#224; massa gorda e obesidade ( <italic>FTO</italic> , do ingl&#234;s <italic>fat mass and obesity</italic> - <italic>associated gene</italic> ) foi avaliado devido &#224; sua associa&#231;&#227;o (alelo A) com obesidade em estudos pr&#233;vios no Brasil.<sup><xref rid="B26" ref-type="bibr">26</xref></sup> A genotipagem (alelos AA, AT, TT) foi realizada por rea&#231;&#227;o em cadeia da polimerase (PCR) em tempo real utilizando o sistema TaqMan&#174; conforme descrito previamente.<sup><xref rid="B27" ref-type="bibr">27</xref></sup></p>
      <p>A APCR foi avaliada indiretamente por testes de exerc&#237;cios subm&#225;ximos. O teste de caminhada/corrida de nove minutos foi usado no <italic>baseline</italic> , e o teste de seis minutos de caminhada/corrida foi usado no <italic>follow-up</italic> , seguindo-se os protocolos do Projeto Esporte Brasil (PROESP-BR).<sup><xref rid="B28" ref-type="bibr">28</xref> , <xref rid="B29" ref-type="bibr">29</xref> </sup> Para ambos os testes, as crian&#231;as e os adolescentes foram divididos em grupos, de acordo com a dist&#226;ncia do percurso de corrida. Os participantes foram instru&#237;dos a correrem a maior dist&#226;ncia poss&#237;vel, evitando picos de velocidade intercalados por longas caminhadas. Durante o teste, os participantes foram estimulados verbalmente. Ao final do teste, ap&#243;s um sinal, os estudantes pararam de correr e permaneceram no local em que pararam at&#233; que a dist&#226;ncia percorrida (em metros) fosse registrada. O resultado foi classificado como uma vari&#225;vel categ&#243;rica, dicotomizada como valores &#8220;altos&#8221; e &#8220;baixos&#8221; de acordo com o manual de testes do PROESP-BR.<sup><xref rid="B30" ref-type="bibr">30</xref></sup></p>
      <sec>
        <title>An&#225;lise estat&#237;stica</title>
        <p>Os dados foram analisados com o programa <italic>Statistical Package for the Social Sciences </italic> (SPSS), vers&#227;o 23.0 (IBM, Armonk, NY, EUA). As caracter&#237;sticas da amostra foram descritas nos dois per&#237;odos de avalia&#231;&#227;o (2011/12 e 2014/15) como valores absolutos e porcentagens por sexo, idade, polimorfismo rs9939609 (gene <italic>FTO</italic> ) e cor de pele/etnia. A incid&#234;ncia cumulativa (novos casos de hipertens&#227;o) no per&#237;odo de tr&#234;s anos foi calculada.</p>
        <p>Um modelo de regress&#227;o log&#237;stica multinomial foi constru&#237;do, com hipertens&#227;o como a vari&#225;vel dependente (normotenso foi a categoria de refer&#234;ncia), e IMC, CC, %GC, glicemia, dislipidemia, polimorfismo rs9939609 (gene <italic>FTO</italic> ) e APCR como as vari&#225;veis independentes, com <italic>odds ratio</italic> (OR) e intervalo de confian&#231;a (IC) de 95% para indicar as chances de mudan&#231;a de normotenso para <italic>borderline</italic> ou de normotenso para hipertenso. Tr&#234;s modelos foram constru&#237;dos, uma vez que as medidas de adiposidade est&#227;o altamente associadas e n&#227;o devem ser inseridas em um mesmo modelo como vari&#225;veis independentes: Modelo 1 com IMC, Modelo 2 com CC, e Modelo 3 com %GC, todos ajustados para idade, sexo e cor de pele. O n&#237;vel de signific&#226;ncia estat&#237;stica foi estabelecido em p &lt; 0,05.</p>
      </sec>
    </sec>
    <sec sec-type="results">
      <title>Resultados</title>
      <p>Dados dos participantes sobre IMC, CC, %GC, glicemia, dislipidemia, e APCR est&#227;o apresentados na <xref rid="t1" ref-type="table">Tabela 1</xref> . Das 469 crian&#231;as e adolescentes avaliados, 202 (43,1%) eram do sexo masculino, e 77,0% eram brancos. Quanto ao polimorfismo rs9939609 ( <italic>FTO</italic> ), 37,5% foram classificados como alelo TT, 47,6% como AT e 14,9% como AA.</p>
      <p>
        <table-wrap id="t1">
          <label>Tabela 1</label>
          <caption>
            <title>&#8211; Descri&#231;&#227;o do perfil metab&#243;lico dos participantes por ano de avalia&#231;&#227;o</title>
          </caption>
          <table frame="hsides" rules="groups">
            <colgroup width="33%">
              <col/>
              <col/>
              <col/>
            </colgroup>
            <thead>
              <tr>
                <th align="left" rowspan="2">Vari&#225;veis</th>
                <th colspan="2">n (%)</th>
              </tr>
              <tr>
                <th><italic>Baseline</italic> 2011/12</th>
                <th><italic>Follow-up</italic> 2014/15</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td>
                  <bold>IMC</bold>
                </td>
                <td> </td>
                <td> </td>
              </tr>
              <tr>
                <td> Baixo peso</td>
                <td align="center">6 (1,3)</td>
                <td align="center">4 (0,9)</td>
              </tr>
              <tr>
                <td> Normal</td>
                <td align="center">283 (60,3)</td>
                <td align="center">289 (61,6)</td>
              </tr>
              <tr>
                <td> Sobrepeso</td>
                <td align="center">92 (19,6)</td>
                <td align="center">90 (19,2)</td>
              </tr>
              <tr>
                <td> Obesidade</td>
                <td align="center">88 (18,8)</td>
                <td align="center">86 (18,3)</td>
              </tr>
              <tr>
                <td>
                  <bold>CC</bold>
                </td>
                <td> </td>
                <td> </td>
              </tr>
              <tr>
                <td> Baixo risco</td>
                <td align="center">357 (76,1)</td>
                <td align="center">366 (78,0)</td>
              </tr>
              <tr>
                <td> Alto risco</td>
                <td align="center">112 (23,9)</td>
                <td align="center">103 (22,0)</td>
              </tr>
              <tr>
                <td>
                  <bold>%GC</bold>
                </td>
                <td> </td>
                <td> </td>
              </tr>
              <tr>
                <td> Baixo</td>
                <td align="center">268 (57,1)</td>
                <td align="center">297 (63,3)</td>
              </tr>
              <tr>
                <td> Alto</td>
                <td align="center">201 (42,9)</td>
                <td align="center">172 (36,7)</td>
              </tr>
              <tr>
                <td>
                  <bold>Glicose</bold>
                </td>
                <td> </td>
                <td> </td>
              </tr>
              <tr>
                <td> Normal</td>
                <td align="center">356 (83,0)</td>
                <td align="center">396 (85,5)</td>
              </tr>
              <tr>
                <td> Alto</td>
                <td align="center">73 (17,0)</td>
                <td align="center">67 (14,5)</td>
              </tr>
              <tr>
                <td>
                  <bold>Dislipidemia</bold>
                </td>
                <td> </td>
                <td> </td>
              </tr>
              <tr>
                <td> N&#227;o</td>
                <td align="center">249 (54,8)</td>
                <td align="center">249 (54,8)</td>
              </tr>
              <tr>
                <td> Sim</td>
                <td align="center">205 (45,2)</td>
                <td align="center">205 (45,2)</td>
              </tr>
              <tr>
                <td>
                  <bold>APCR</bold>
                </td>
                <td> </td>
                <td> </td>
              </tr>
              <tr>
                <td> Baixo</td>
                <td align="center">206 (43,9)</td>
                <td align="center">261 (56,5)</td>
              </tr>
              <tr>
                <td> Alto</td>
                <td align="center">263 (56,1)</td>
                <td align="center">201 (43,5)</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn id="TFN1">
              <p>
                <italic>IMC: &#237;ndice de massa corporal; CC: circunfer&#234;ncia da cintura; %GC: porcentagem de gordura corporal; APCR: aptid&#227;o cardiorrespirat&#243;ria.</italic>
              </p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
      </p>
      <p>A <xref rid="t2" ref-type="table">Tabela 2</xref> descreve a incid&#234;ncia de press&#227;o arterial alterada ao longo dos tr&#234;s anos. A maioria dos indiv&#237;duos continuaram classificados como normotensos, e aproximadamente um ter&#231;o dos normotensos apresentaram aumento nos n&#237;veis sangu&#237;neos (passando para as categorias hipertens&#227;o <italic>borderline</italic> /hipertens&#227;o). Vale mencionar que um n&#250;mero consider&#225;vel de indiv&#237;duos <italic>borderline</italic> e hipertensos tornaram-se normotensos.</p>
      <p>
        <table-wrap id="t2">
          <label>Tabela 2</label>
          <caption>
            <title>&#8211; Compara&#231;&#227;o longitudinal dos estudantes quanto &#224;s categorias de press&#227;o arterial</title>
          </caption>
          <table frame="hsides" rules="groups">
            <colgroup width="50%">
              <col/>
              <col/>
            </colgroup>
            <thead>
              <tr>
                <th align="left">Press&#227;o arterial</th>
                <th>n (%)</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td>Normotenso (mantiveram)</td>
                <td align="center">309 (65,9)</td>
              </tr>
              <tr>
                <td>Normotenso para <italic>borderline</italic></td>
                <td align="center">60 (12,8)</td>
              </tr>
              <tr>
                <td>Normotenso para hipertenso</td>
                <td align="center">54 (11,5)</td>
              </tr>
              <tr>
                <td><italic>Borderline</italic> (mantiveram)</td>
                <td align="center">2 (0,4)</td>
              </tr>
              <tr>
                <td><italic>Borderline</italic> para normotenso</td>
                <td align="center">6 (1,3)</td>
              </tr>
              <tr>
                <td><italic>Borderline</italic> para hipertenso</td>
                <td align="center">6 (1,3)</td>
              </tr>
              <tr>
                <td>Hipertenso (mantiveram)</td>
                <td align="center">9 (1,9)</td>
              </tr>
              <tr>
                <td>Hipertenso para normotenso</td>
                <td align="center">15 (3,2)</td>
              </tr>
              <tr>
                <td>Hipertenso para <italic>borderline</italic></td>
                <td align="center">8 (1,7)</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
      </p>
      <p>As <xref rid="f03" ref-type="fig">Figuras 2</xref> e <xref rid="f04" ref-type="fig">3</xref> mostram as mudan&#231;as nas classifica&#231;&#245;es da PAS e PAD ao longo do tempo.</p>
      <p>
        <fig id="f03">
          <label>Figura 2</label>
          <caption>
            <title>&#8211; Incid&#234;ncia de mudan&#231;as na press&#227;o arterial sist&#243;lica ao longo de tr&#234;s anos.</title>
          </caption>
          <graphic xlink:href="1678-4170-abc-120-02-e20220070-20070-gf03.tif"/></fig>
      </p>
      <p>
        <fig id="f04">
          <label>Figura 3</label>
          <caption>
            <title>&#8211; Incid&#234;ncia de mudan&#231;as na press&#227;o arterial diast&#243;lica ao longo de tr&#234;s anos.</title>
          </caption>
          <graphic xlink:href="1678-4170-abc-120-02-e20220070-20070-gf04.tif"/></fig>
      </p>
      <p>A <xref rid="t3" ref-type="table">Tabela 3</xref> mostra as chances de hipertens&#227;o por par&#226;metros de adiposidade (IMC, CC e %GC) e dados bioqu&#237;micos, gen&#233;ticos e de APCR. Crian&#231;as e adolescentes com sobrepeso ou obesidade de acordo com o IMC no <italic>baseline</italic> apresentavam maior probabilidade de se tornarem hipertensos <italic>borderline</italic> ou hipertensos no decorrer de tr&#234;s anos. Valores aumentados de CC foram associados com um risco elevado de se desenvolver hipertens&#227;o, e valores maiores de %GC foram associados a mudan&#231;as nas categorias de press&#227;o arterial, de normotenso para <italic>borderline</italic> e de normotenso para hipertenso no per&#237;odo do estudo.</p>
      <p>
        <table-wrap id="t3">
          <label>Tabela 3</label>
          <caption>
            <title>&#8211; Fatores associados com mudan&#231;a na press&#227;o arterial durante os tr&#234;s anos de acompanhamento</title>
          </caption>
          <table frame="hsides" rules="groups">
            <colgroup width="20%">
              <col/>
              <col/>
              <col/>
              <col/>
              <col/>
            </colgroup>
            <thead>
              <tr>
                <th align="left" style="font-weight:normal"> </th>
                <th colspan="4">Mudan&#231;a de classifica&#231;&#227;o</th>
              </tr>
              <tr>
                <th align="left">
                  <italic>Baseline</italic>
                </th>
                <th colspan="2">Normotenso &#61672; <italic>Borderline</italic></th>
                <th colspan="2">Normotenso &#61672; Hipertenso</th>
              </tr>
              <tr>
                <th align="left" style="font-weight:normal"> </th>
                <th>OR (IC95%)</th>
                <th>p</th>
                <th>OR (IC95%)</th>
                <th>p</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td>
                  <bold>Modelo 1: IMC</bold>
                </td>
                <td> </td>
                <td> </td>
                <td> </td>
                <td> </td>
              </tr>
              <tr>
                <td>IMC</td>
                <td> </td>
                <td> </td>
                <td> </td>
                <td> </td>
              </tr>
              <tr>
                <td> Baixo peso/Peso normal</td>
                <td align="center">1</td>
                <td> </td>
                <td align="center">1</td>
                <td> </td>
              </tr>
              <tr>
                <td> Sobrepeso</td>
                <td align="center">3,22 (1,08-9,55)</td>
                <td align="center">0,035</td>
                <td align="center">1,69 (0,58-4,90)</td>
                <td align="center">0,336</td>
              </tr>
              <tr>
                <td> Obesidade</td>
                <td align="center">4,05 (1,68-9,75)</td>
                <td align="center">0,002</td>
                <td align="center">4,84 (1,57-14,95)</td>
                <td align="center">0,006</td>
              </tr>
              <tr>
                <td>Dislipidemia</td>
                <td> </td>
                <td> </td>
                <td> </td>
                <td> </td>
              </tr>
              <tr>
                <td> N&#227;o</td>
                <td align="center">1</td>
                <td> </td>
                <td align="center">1</td>
                <td> </td>
              </tr>
              <tr>
                <td> Sim</td>
                <td align="center">0,86 (0,40-1,84)</td>
                <td align="center">0,695</td>
                <td align="center">1,60 (0,71-3,61)</td>
                <td align="center">0,252</td>
              </tr>
              <tr>
                <td>Glicose</td>
                <td> </td>
                <td> </td>
                <td> </td>
                <td> </td>
              </tr>
              <tr>
                <td> Normal</td>
                <td align="center">1</td>
                <td> </td>
                <td align="center">1</td>
                <td> </td>
              </tr>
              <tr>
                <td> Alto</td>
                <td align="center">1,54 (0,60-3,96)</td>
                <td align="center">0,370</td>
                <td align="center">1,94 (0,74-5,07)</td>
                <td align="center">0,177</td>
              </tr>
              <tr>
                <td>Polimorfismo rs9939609 ( <italic>FTO</italic> )</td>
                <td> </td>
                <td> </td>
                <td> </td>
                <td> </td>
              </tr>
              <tr>
                <td> TT</td>
                <td align="center">1</td>
                <td> </td>
                <td align="center">1</td>
                <td> </td>
              </tr>
              <tr>
                <td> AT</td>
                <td align="center">1,15 (0,48-2,74)</td>
                <td align="center">0,750</td>
                <td align="center">0,84 (0,36-1,97)</td>
                <td align="center">0,686</td>
              </tr>
              <tr>
                <td> AA</td>
                <td align="center">1,68 (0,59-4,77)</td>
                <td align="center">0,332</td>
                <td align="center">0,58 (0,15-2,26)</td>
                <td align="center">0,433</td>
              </tr>
              <tr>
                <td>APCR</td>
                <td> </td>
                <td> </td>
                <td> </td>
                <td> </td>
              </tr>
              <tr>
                <td> Alta</td>
                <td align="center">1</td>
                <td> </td>
                <td align="center">1</td>
                <td> </td>
              </tr>
              <tr>
                <td> Baixa</td>
                <td align="center">1,60 (0,73-3,51)</td>
                <td align="center">0,244</td>
                <td align="center">1,19 (0,51-2,81)</td>
                <td align="center">0,683</td>
              </tr>
              <tr>
                <td>
                  <bold>Modelo 2: CC</bold>
                </td>
                <td> </td>
                <td> </td>
                <td> </td>
                <td> </td>
              </tr>
              <tr>
                <td>CC</td>
                <td> </td>
                <td> </td>
                <td> </td>
                <td> </td>
              </tr>
              <tr>
                <td> Baixo risco</td>
                <td align="center">1</td>
                <td> </td>
                <td align="center">1</td>
                <td> </td>
              </tr>
              <tr>
                <td> Alto risco</td>
                <td align="center">2,46 (0,99-6,12)</td>
                <td align="center">0,052</td>
                <td align="center">3,41 (1,26-9,19)</td>
                <td align="center">0,016</td>
              </tr>
              <tr>
                <td>Dislipidemia</td>
                <td> </td>
                <td> </td>
                <td> </td>
                <td> </td>
              </tr>
              <tr>
                <td> N&#227;o</td>
                <td align="center">1</td>
                <td> </td>
                <td align="center">1</td>
                <td> </td>
              </tr>
              <tr>
                <td> Sim</td>
                <td align="center">0,95 (0,45-2,01)</td>
                <td align="center">0,898</td>
                <td align="center">1,65 (0,74-3,70)</td>
                <td align="center">0,224</td>
              </tr>
              <tr>
                <td>Glicose</td>
                <td> </td>
                <td> </td>
                <td> </td>
                <td> </td>
              </tr>
              <tr>
                <td> Normal</td>
                <td align="center">1</td>
                <td> </td>
                <td align="center">1</td>
                <td> </td>
              </tr>
              <tr>
                <td> Alto</td>
                <td align="center">1,78 (0,70-4,49)</td>
                <td align="center">0,225</td>
                <td align="center">1,92 (0,74-5,01)</td>
                <td align="center">0,179</td>
              </tr>
              <tr>
                <td>Polimorfismo rs9939609 ( <italic>FTO</italic> )</td>
                <td> </td>
                <td> </td>
                <td> </td>
                <td> </td>
              </tr>
              <tr>
                <td> TT</td>
                <td align="center">1</td>
                <td> </td>
                <td align="center">1</td>
                <td> </td>
              </tr>
              <tr>
                <td> AT</td>
                <td align="center">1,05 (0,45-2,47)</td>
                <td align="center">0,902</td>
                <td> </td>
                <td> </td>
              </tr>
              <tr>
                <td> AA</td>
                <td align="center">1,57 (0,56-4,38)</td>
                <td align="center">0,387</td>
                <td align="center">0,53 (0,14-2,06)</td>
                <td align="center">0,363</td>
              </tr>
              <tr>
                <td>APCR</td>
                <td> </td>
                <td> </td>
                <td> </td>
                <td> </td>
              </tr>
              <tr>
                <td> Alta</td>
                <td align="center">1</td>
                <td> </td>
                <td align="center">1</td>
                <td> </td>
              </tr>
              <tr>
                <td> Baixa</td>
                <td align="center">1,65 (0,76-3,59)</td>
                <td align="center">0,204</td>
                <td align="center">1,34 (0,58-3,09)</td>
                <td align="center">0,489</td>
              </tr>
              <tr>
                <td>
                  <bold>Modelo 3: %GC</bold>
                </td>
                <td> </td>
                <td> </td>
                <td> </td>
                <td> </td>
              </tr>
              <tr>
                <td>%GC</td>
                <td> </td>
                <td> </td>
                <td> </td>
                <td> </td>
              </tr>
              <tr>
                <td> Baixa</td>
                <td align="center">1</td>
                <td> </td>
                <td align="center">1</td>
                <td> </td>
              </tr>
              <tr>
                <td> Alta</td>
                <td align="center">2,28 (1,04-4,97)</td>
                <td align="center">0,039</td>
                <td align="center">2,49 (1,08-5,75)</td>
                <td align="center">0,033</td>
              </tr>
              <tr>
                <td>Dislipidemia</td>
                <td> </td>
                <td> </td>
                <td> </td>
                <td> </td>
              </tr>
              <tr>
                <td> N&#227;o</td>
                <td align="center">1</td>
                <td> </td>
                <td align="center">1</td>
                <td> </td>
              </tr>
              <tr>
                <td> Sim</td>
                <td align="center">0,93 (0,44-1,96)</td>
                <td align="center">0,845</td>
                <td align="center">1,58 (0,71-3,52)</td>
                <td align="center">0,265</td>
              </tr>
              <tr>
                <td>Glicose</td>
                <td> </td>
                <td> </td>
                <td> </td>
                <td> </td>
              </tr>
              <tr>
                <td> Normal</td>
                <td align="center">1</td>
                <td> </td>
                <td align="center">1</td>
                <td> </td>
              </tr>
              <tr>
                <td> Alta</td>
                <td align="center">1,59 (0,63-4,01)</td>
                <td align="center">0,327</td>
                <td align="center">1,68 (0,65-4,34)</td>
                <td align="center">0,280</td>
              </tr>
              <tr>
                <td>Polimorfismo rs9939609 ( <italic>FTO</italic> )</td>
                <td> </td>
                <td> </td>
                <td> </td>
                <td> </td>
              </tr>
              <tr>
                <td> TT</td>
                <td align="center">1</td>
                <td> </td>
                <td align="center">1</td>
                <td> </td>
              </tr>
              <tr>
                <td> AT</td>
                <td align="center">1,12 (0,48-2,61)</td>
                <td align="center">0,799</td>
                <td align="center">0,90 (0,39-2,09)</td>
                <td align="center">0,807</td>
              </tr>
              <tr>
                <td> AA</td>
                <td align="center">1,74 (0,62-4,85)</td>
                <td align="center">0,292</td>
                <td align="center">0,57 (0,15-2,21)</td>
                <td align="center">0,419</td>
              </tr>
              <tr>
                <td>APCR</td>
                <td> </td>
                <td> </td>
                <td> </td>
                <td> </td>
              </tr>
              <tr>
                <td> Alta</td>
                <td align="center">1</td>
                <td> </td>
                <td align="center">1</td>
                <td> </td>
              </tr>
              <tr>
                <td> Baixa</td>
                <td align="center">1,61 (0,74-3,49)</td>
                <td align="center">0,229</td>
                <td align="center">1,35 (0,59-3,08)</td>
                <td align="center">0,479</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn id="TFN2">
              <p>
                <italic>IMC: &#237;ndice de massa corporal; CC: circunfer&#234;ncia da cintura; %GC: porcentagem de gordura corporal; APCR: aptid&#227;o cardiorrespirat&#243;ria.</italic>
              </p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
      </p>
    </sec>
    <sec sec-type="discussion">
      <title>Discuss&#227;o</title>
      <p>O objetivo deste estudo foi determinar a incid&#234;ncia de hipertens&#227;o e relacion&#225;-la &#224;s vari&#225;veis cardiometab&#243;licas (peso, APCR, e perfil bioqu&#237;mico) e aos gen&#243;tipos do polimorfismo rs9939609 do gene FTO de crian&#231;as e adolescentes brasileiros Nossos resultados identificaram 12,8% de indiv&#237;duos normotensos no <italic>baseline</italic> que se tornaram <italic>borderline</italic> , e 11,5% desses mudaram para hipertensos. Importante mencionar que essas associa&#231;&#245;es se deram independentemente de crescimento ou est&#225;gio de desenvolvimento. Al&#233;m disso, em rela&#231;&#227;o &#224;s vari&#225;veis de adiposidade, crian&#231;as e adolescentes com sobrepeso ou obesidade de acordo com IMC (modelo 1) no <italic>baseline</italic> apresentaram maior probabilidade de se tornarem hipertensos <italic>borderline</italic> , e os obesos apresentaram maior probabilidade de se tornarem hipertensos no decorrer de tr&#234;s anos. Valores de alto risco para CC (modelo 2) foram associados com hipertens&#227;o, e valores mais altos de %GC (modelo 3) foram associados com desenvolvimento tanto de hipertens&#227;o como de hipertens&#227;o <italic>borderline</italic> .</p>
      <p>A incid&#234;ncia de n&#237;veis elevados de press&#227;o arterial em crian&#231;as e adolescentes vem aumentando.<sup><xref rid="B4" ref-type="bibr">4</xref></sup> Esse aumento tem sido atribu&#237;do &#224; alta incid&#234;ncia de sobrepeso e obesidade nessa popula&#231;&#227;o, uma vez que ganho de peso excessivo, principalmente quando associado ao aumento de adiposidade visceral, &#233; uma causa importante de hipertens&#227;o.<sup><xref rid="B31" ref-type="bibr">31</xref></sup> Segundo um grande estudo com adolescentes brasileiros, a maior preval&#234;ncia de hipertens&#227;o no Brasil encontra-se na regi&#227;o sul, a mesma popula&#231;&#227;o avaliada no presente estudo. A regi&#227;o sul do Brasil tamb&#233;m apresenta a maior preval&#234;ncia de obesidade, sobrepeso e sedentarismo.<sup><xref rid="B32" ref-type="bibr">32</xref></sup></p>
      <p>Nosso estudo mostrou que crian&#231;as e adolescentes com sobrepeso ou obesidade de acordo com IMC (modelo 1) no <italic>baseline</italic> apresentaram maior probabilidade de se tornarem <italic>borderline </italic> (OR: 3,22; IC95%: 1,08-9,55; obesidade OR: 4,05; IC95%: 1,68-9,75) ou hipertensos (obesidade OR: 4,84; IC95%: 1,57-14,95) no decorrer de tr&#234;s anos. Ainda, outros estudos com popula&#231;&#245;es de mesma faixa et&#225;ria mostraram associa&#231;&#245;es entre IMC e n&#237;veis elevados de press&#227;o arterial.<sup><xref rid="B33" ref-type="bibr">33</xref></sup> Um estudo<sup><xref rid="B34" ref-type="bibr">34</xref></sup> similar, por&#233;m transversal, teve como objetivo verificar a associa&#231;&#227;o entre sobrepeso/obesidade e press&#227;o arterial elevada em estudantes brasileiros com idade entre seis e 10 anos. A obesidade aumentou em duas vezes a chance de press&#227;o arterial elevada em crian&#231;as com idade de 6-7 anos. Em crian&#231;as com idade de 8-9 anos, o sobrepeso duplicou o risco de press&#227;o arterial elevada, e a obesidade aumentou em quatro vezes essa chance.<sup><xref rid="B34" ref-type="bibr">34</xref></sup> Em outro estudo,<sup><xref rid="B35" ref-type="bibr">35</xref></sup> conduzido com crian&#231;as e adolescentes chineses com idade entre 7 e 18 anos, uma alta preval&#234;ncia de press&#227;o arterial elevada foi encontrada em indiv&#237;duos com sobrepeso (19%) e obesidade (23,2%).<sup><xref rid="B35" ref-type="bibr">35</xref></sup></p>
      <p>Em nossos resultados (modelo 2), CC de &#8220;alto risco&#8221; foi associada ao desenvolvimento de hipertens&#227;o no <italic>follow-up</italic> (OR: 3,41; IC95%: 1,26-9,19), o que &#233; corroborado por v&#225;rios estudos.<sup><xref rid="B36" ref-type="bibr">36</xref> - <xref rid="B39" ref-type="bibr">39</xref> </sup> H&#225; achados indicando que tanto a CC como o IMC s&#227;o bons preditores de n&#237;veis elevados de press&#227;o arterial em cada fase da vida,<sup><xref rid="B2" ref-type="bibr">2</xref></sup> incluindo um estudo que mostrou que a CC foi um bom preditor de hipertens&#227;o, mesmo quando o IMC era normal.<sup><xref rid="B40" ref-type="bibr">40</xref></sup> Contudo, outro estudo mostrou que um IMC elevado, mas n&#227;o CC ou %GC, foi associado com alto risco de hipertens&#227;o em crian&#231;as chinesas com peso normal.<sup><xref rid="B41" ref-type="bibr">41</xref></sup> Como se sabe, a distribui&#231;&#227;o anormal ou um excesso no tecido adiposo afeta o sistema renina-angiotensina-aldosterona, e o aumento na produ&#231;&#227;o de &#225;cidos graxos n&#227;o esterificados e de citocinas n&#227;o inflamat&#243;rias (por exemplo, interleucina 6). Ainda, a obesidade est&#225; associada com um estado de hiperinsulinemia, que ativa o sistema nervoso simp&#225;tico. Essas altera&#231;&#245;es envolvem um aumento na reabsor&#231;&#227;o renal e no volume intravascular, e vasoconstri&#231;&#227;o, que resulta em hipertens&#227;o arterial.<sup><xref rid="B42" ref-type="bibr">42</xref></sup></p>
      <p>Uma revis&#227;o sistem&#225;tica sobre adiposidade abdominal e fatores de risco cardiometab&#243;licos mostrou que a medida da press&#227;o arterial foi o par&#226;metro cardiometab&#243;lico mais comum entre os estudos.<sup><xref rid="B43" ref-type="bibr">43</xref></sup> A maioria desses estudos confirmou a associa&#231;&#227;o entre n&#237;veis elevados de press&#227;o arterial e obesidade abdominal, contudo, a maioria era transversal. Por outro lado, alguns estudos n&#227;o confirmaram que a CC foi um melhor preditor que o IMC para identificar crian&#231;as com n&#237;veis elevados de press&#227;o arterial.<sup><xref rid="B44" ref-type="bibr">44</xref></sup> Uma meta-an&#225;lise incluiu 23 estudos observacionais longitudinais e mostrou que a CC e o IMC foram bons preditores de diabetes, mas n&#227;o de hipertens&#227;o.<sup><xref rid="B45" ref-type="bibr">45</xref></sup></p>
      <p>Ainda, crian&#231;as e adolescentes com n&#237;veis mais altos de %GC no <italic>baseline</italic> apresentaram maior probabilidade de se tornarem <italic>borderline </italic> (OR: 2,28; IC95%: 1,04-4,97) ou hipertensos (OR: 2,49; IC95%: 1,08-5,75), corroborando alguns achados na literatura.<sup><xref rid="B46" ref-type="bibr">46</xref> , <xref rid="B47" ref-type="bibr">47</xref> </sup> Uma porcentagem mais alta de gordura corporal poderia aumentar o risco de hipertens&#227;o, e sua redu&#231;&#227;o poderia ser ben&#233;fico para a preven&#231;&#227;o e controle da hipertens&#227;o em crian&#231;as, como demonstrado por Tao et al.<sup><xref rid="B47" ref-type="bibr">47</xref></sup> Em seu estudo<sup><xref rid="B47" ref-type="bibr">47</xref></sup> e no presente estudo, todos os resultados relacionados &#224; adiposidade apontam para a mesma dire&#231;&#227;o &#8211; a associa&#231;&#227;o com n&#237;veis press&#243;ricos elevados. Um estudo<sup><xref rid="B48" ref-type="bibr">48</xref></sup> com uma popula&#231;&#227;o adulta mostrou que a perda de peso teve efeitos ben&#233;ficos sobre a hipertens&#227;o e eventos cardiovasculares incidentes. Sabe-se que mudan&#231;as no estilo de vida t&#234;m um impacto sobre os n&#237;veis de press&#227;o arterial e refor&#231;am que a redu&#231;&#227;o de peso &#233; uma importante meta na preven&#231;&#227;o prim&#225;ria de eventos cardiovasculares.<sup><xref rid="B48" ref-type="bibr">48</xref></sup> Uma redu&#231;&#227;o de 5% no peso corporal est&#225; associada a uma diminui&#231;&#227;o de 20-30% na press&#227;o arterial,<sup><xref rid="B49" ref-type="bibr">49</xref></sup> importante indicador de melhora na fun&#231;&#227;o vascular.<sup><xref rid="B50" ref-type="bibr">50</xref></sup> Outro estudo tamb&#233;m mostrou a associa&#231;&#227;o entre n&#237;veis de press&#227;o arterial e obesidade, sugerindo que os n&#237;veis elevados na press&#227;o possam estar mais relacionados &#224; composi&#231;&#227;o que ao peso corporal, uma vez que, em algumas situa&#231;&#245;es, o peso corporal, e consequentemente o IMC s&#227;o mais altos, mas a %GC &#233; baixa. Achados do mesmo estudo sugerem que a perda e o ganho de peso, que alteram o perfil antropom&#233;trico, t&#234;m um grande impacto na revers&#227;o e no desenvolvimento de hipertens&#227;o, respectivamente.<sup><xref rid="B51" ref-type="bibr">51</xref></sup></p>
      <p>Um estudo de acompanhamento indicou que a press&#227;o arterial apresenta uma estabilidade moderada da inf&#226;ncia &#224; adolesc&#234;ncia ou fase inicial adulta, j&#225; que as medidas de press&#227;o arterial parecem ser preditores independentes de medidas futuras.<sup><xref rid="B52" ref-type="bibr">52</xref></sup> Outro estudo de acompanhamento, desta vez incluindo participantes da fase tardia adulta &#224; fase inicial da adolesc&#234;ncia, mostrou estabilidade baixa &#224; moderada para PAS e para PAD ao longo de tr&#234;s anos.<sup><xref rid="B53" ref-type="bibr">53</xref></sup> Essa tend&#234;ncia pode ser explicada por mudan&#231;as no perfil antropom&#233;trico ao longo do tempo,<sup><xref rid="B49" ref-type="bibr">49</xref></sup> tais como aumento na adiposidade central, principal fator de risco da s&#237;ndrome metab&#243;lica,<sup><xref rid="B54" ref-type="bibr">54</xref></sup> a qual pode levar a mudan&#231;as na press&#227;o arterial, nos lip&#237;dios circulantes e na glicemia.<sup><xref rid="B50" ref-type="bibr">50</xref></sup></p>
      <p>No presente estudo, houve casos de pacientes que mudaram do estado de hipertens&#227;o <italic>borderline</italic> ou hipertens&#227;o para a categoria de normotensos. Uma poss&#237;vel explica&#231;&#227;o &#233; a influ&#234;ncia da escola, onde os alunos participam de atividades f&#237;sicas que podem melhorar sua condi&#231;&#227;o f&#237;sica e consequentemente sua sa&#250;de.</p>
      <p>Nenhum dos outros fatores de risco mostrou uma associa&#231;&#227;o estatisticamente significativa com hipertens&#227;o <italic>borderline</italic> ou hipertens&#227;o em nenhum dos modelos, talvez por se tratar de um est&#225;gio muito precoce da vida para promoverem consequ&#234;ncias na sa&#250;de. Apesar da forte rela&#231;&#227;o entre APCR e composi&#231;&#227;o corporal, do fato de que a APCR tenha se mostrado um importante fator de risco modific&#225;vel da hipertens&#227;o, bem como um forte preditor negativo independente da press&#227;o arterial em crian&#231;as e adolescentes,<sup><xref rid="B16" ref-type="bibr">16</xref></sup> n&#227;o encontramos associa&#231;&#227;o estatisticamente significativa entre elas. Assim, a preven&#231;&#227;o da doen&#231;a cardiovascular deveria iniciar-se na inf&#226;ncia por meio de um rastreamento regular para hipertens&#227;o, aconselhamento para um estilo saud&#225;vel, e preven&#231;&#227;o de fatores de risco modific&#225;veis para IMC, CC e %GC.<sup><xref rid="B55" ref-type="bibr">55</xref></sup></p>
      <p>O presente estudo tem algumas limita&#231;&#245;es: nossas an&#225;lises n&#227;o controlaram atividade f&#237;sica, est&#225;gio de matura&#231;&#227;o, e comportamentos alimentares; o IMC foi usado como um marcador de adiposidade, embora haja m&#233;todos mais diretos para a avaliar. Ainda, a press&#227;o arterial foi medida somente duas vezes por per&#237;odo de avalia&#231;&#227;o, apesar de recomenda&#231;&#245;es<sup><xref rid="B18" ref-type="bibr">18</xref></sup> para tr&#234;s medidas em cada avalia&#231;&#227;o. Contudo, nosso estudo &#233; compar&#225;vel &#224; maioria dos estudos epidemiol&#243;gicos que, por quest&#245;es de custo e log&#237;stica, realizam medidas &#250;nicas em cada per&#237;odo de avalia&#231;&#227;o. Como pontos fortes, nosso estudo avaliou uma amostra selecionada aleatoriamente no <italic>baseline</italic> para medir a press&#227;o arterial, pelo m&#233;todo auscultat&#243;rio, pelo mesmo avaliador em ambos os per&#237;odos, e de acordo com as mesmas recomenda&#231;&#245;es.<sup><xref rid="B18" ref-type="bibr">18</xref></sup></p>
    </sec>
    <sec sec-type="conclusions">
      <title>Conclus&#227;o</title>
      <p>O presente estudo longitudinal mostrou um aumento no n&#250;mero de casos, representado pela alta incid&#234;ncia de hipertens&#227;o em crian&#231;as e adolescentes, em compara&#231;&#227;o a estudos anteriores. Al&#233;m disso, nossos resultados mostraram que crian&#231;as e adolescentes com medidas maiores de IMC, CC e %GC no <italic>baseline</italic> tinham maior probabilidade de desenvolverem hipertens&#227;o no decorrer dos tr&#234;s anos, destacando a import&#226;ncia do cuidado da sa&#250;de da crian&#231;a e do adolescente na preven&#231;&#227;o de problemas em idades futuras.</p>
    </sec>
  </body>
  <back>
    <ack>
      <title>Agradecimentos</title>
      <p>Agradecemos todos os participantes pela contribui&#231;&#227;o &#224; esta pesquisa, a Universidade de Santa Cruz do Sul (UNISC) e a Coordena&#231;&#227;o de Aperfei&#231;oamento de Pessoal de N&#237;vel Superior (CAPES).</p>
    </ack>
    <ref-list>
      <title>Refer&#234;ncias</title>
      <ref id="B1">
        <label>1</label>
        <mixed-citation>1. Wang S, Shen G, Jiang S, Xu H, Li M, Wang Z, et al. Nutrient Status of Vitamin D Among Chinese Children. Nutrients. 2017;9(4):319. doi: 10.3390/nu9040319.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Shen</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Jiang</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Xu</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>Z</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Nutrient Status of Vitamin D Among Chinese Children</article-title>
          <source> Nutrients </source>
          <year>2017</year>
          <volume>9</volume>
          <issue>4</issue>
          <fpage>319</fpage>
          <issue-id pub-id-type="doi">10.3390/nu9040319</issue-id>
        </element-citation>
      </ref>
      <ref id="B2">
        <label>2</label>
        <mixed-citation>2. NCD Risk Factor Collaboration (NCD-RisC). Worldwide Trends in Body-mass Index, Underweight, Overweight, and Obesity from 1975 to 2016: A Pooled Analysis of 2416 Population-based Measurement Studies in 128&#183;9 Million Children, Adolescents, and Adults. Lancet. 2017;390(10113):2627-42. doi: 10.1016/S0140-6736(17)32129-3.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <collab>NCD Risk Factor Collaboration (NCD-RisC)</collab>
          </person-group>
          <article-title>Worldwide Trends in Body-mass Index, Underweight, Overweight, and Obesity from 1975 to 2016: A Pooled Analysis of 2416 Population-based Measurement Studies in 128&#183;9 Million Children, Adolescents, and Adults</article-title>
          <source> Lancet </source>
          <year>2017</year>
          <volume>390</volume>
          <issue>10113</issue>
          <fpage>2627</fpage>
          <lpage>2642</lpage>
          <pub-id pub-id-type="doi">10.1016/S0140-6736(17)32129-3</pub-id>
        </element-citation>
      </ref>
      <ref id="B3">
        <label>3</label>
        <mixed-citation>3. Song P, Zhang Y, Yu J, Zha M, Zhu Y, Rahimi K, et al. Global Prevalence of Hypertension in Children: A Systematic Review and Meta-analysis. JAMA Pediatr. 2019;173(12):1154-63. doi: 10.1001/jamapediatrics.2019.3310.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Song</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Yu</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Zha</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Zhu</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Rahimi</surname>
              <given-names>K</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Global Prevalence of Hypertension in Children: A Systematic Review and Meta-analysis</article-title>
          <source> JAMA Pediatr </source>
          <year>2019</year>
          <volume>173</volume>
          <issue>12</issue>
          <fpage>1154</fpage>
          <lpage>1163</lpage>
          <issue-id pub-id-type="doi">10.1001/jamapediatrics.2019.3310</issue-id>
        </element-citation>
      </ref>
      <ref id="B4">
        <label>4</label>
        <mixed-citation>4. Sharma AK, Metzger DL, Rodd CJ. Prevalence and Severity of High Blood Pressure Among Children Based on the 2017 American Academy of Pediatrics Guidelines. JAMA Pediatr. 2018;172(6):557-65. doi: 10.1001/jamapediatrics.2018.0223.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sharma</surname>
              <given-names>AK</given-names>
            </name>
            <name>
              <surname>Metzger</surname>
              <given-names>DL</given-names>
            </name>
            <name>
              <surname>Rodd</surname>
              <given-names>CJ</given-names>
            </name>
          </person-group>
          <article-title>Prevalence and Severity of High Blood Pressure Among Children Based on the 2017 American Academy of Pediatrics Guidelines</article-title>
          <source> JAMA Pediatr </source>
          <year>2018</year>
          <volume>172</volume>
          <issue>6</issue>
          <fpage>557</fpage>
          <lpage>565</lpage>
          <issue-id pub-id-type="doi">10.1001/jamapediatrics.2018.0223</issue-id>
        </element-citation>
      </ref>
      <ref id="B5">
        <label>5</label>
        <mixed-citation>5. Ibrahim MM. Hypertension in Developing Countries: A Major Challenge for the Future. Curr Hypertens Rep. 2018;20(5):38. doi: 10.1007/s11906-018-0839-1.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ibrahim</surname>
              <given-names>MM</given-names>
            </name>
          </person-group>
          <article-title>Hypertension in Developing Countries: A Major Challenge for the Future</article-title>
          <source> Curr Hypertens Rep </source>
          <year>2018</year>
          <volume>20</volume>
          <issue>5</issue>
          <size units="pages">38</size>
          <issue-id pub-id-type="doi">10.1007/s11906-018-0839-1</issue-id>
        </element-citation>
      </ref>
      <ref id="B6">
        <label>6</label>
        <mixed-citation>6. Pistoia F, Sacco S, Degan D, Tiseo C, Ornello R, Carolei A. Hypertension and Stroke: Epidemiological Aspects and Clinical Evaluation. High Blood Press Cardiovasc Prev. 2016;23(1):9-18. doi: 10.1007/s40292-015-0115-2.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pistoia</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Sacco</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Degan</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Tiseo</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Ornello</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Carolei</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Hypertension and Stroke: Epidemiological Aspects and Clinical Evaluation</article-title>
          <source> High Blood Press Cardiovasc Prev </source>
          <year>2016</year>
          <volume>23</volume>
          <issue>1</issue>
          <fpage>9</fpage>
          <lpage>18</lpage>
          <issue-id pub-id-type="doi">10.1007/s40292-015-0115-2</issue-id>
        </element-citation>
      </ref>
      <ref id="B7">
        <label>7</label>
        <mixed-citation>7. Kupferman JC, Zafeiriou DI, Lande MB, Kirkham FJ, Pavlakis SG. Stroke and Hypertension in Children and Adolescents. J Child Neurol. 2017;32(4):408-17. doi: 10.1177/0883073816685240.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kupferman</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Zafeiriou</surname>
              <given-names>DI</given-names>
            </name>
            <name>
              <surname>Lande</surname>
              <given-names>MB</given-names>
            </name>
            <name>
              <surname>Kirkham</surname>
              <given-names>FJ</given-names>
            </name>
            <name>
              <surname>Pavlakis</surname>
              <given-names>SG</given-names>
            </name>
          </person-group>
          <article-title>Stroke and Hypertension in Children and Adolescents</article-title>
          <source> J Child Neurol </source>
          <year>2017</year>
          <volume>32</volume>
          <issue>4</issue>
          <fpage>408</fpage>
          <lpage>417</lpage>
          <issue-id pub-id-type="doi">10.1177/0883073816685240</issue-id>
        </element-citation>
      </ref>
      <ref id="B8">
        <label>8</label>
        <mixed-citation>8. Guzik A, Bushnell C. Stroke Epidemiology and Risk Factor Management. Continuum (Minneap Minn). 2017;23(1):15-39. doi: 10.1212/CON.0000000000000416.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Guzik</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Bushnell</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Stroke Epidemiology and Risk Factor Management</article-title>
          <source> Continuum (Minneap Minn) </source>
          <year>2017</year>
          <volume>23</volume>
          <issue>1</issue>
          <fpage>15</fpage>
          <lpage>39</lpage>
          <issue-id pub-id-type="doi">10.1212/CON.0000000000000416</issue-id>
        </element-citation>
      </ref>
      <ref id="B9">
        <label>9</label>
        <mixed-citation>9. Ding W, Cheng H, Chen F, Yan Y, Zhang M, Zhao X, et al. Adipokines are Associated With Hypertension in Metabolically Healthy Obese (MHO) Children and Adolescents: A Prospective Population-Based Cohort Study. J Epidemiol. 2018;28(1):19-26. doi: 10.2188/jea.JE20160141.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ding</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Cheng</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Yan</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Zhao</surname>
              <given-names>X</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Adipokines are Associated With Hypertension in Metabolically Healthy Obese (MHO) Children and Adolescents: A Prospective Population-Based Cohort Study</article-title>
          <source> J Epidemiol </source>
          <year>2018</year>
          <volume>28</volume>
          <issue>1</issue>
          <fpage>19</fpage>
          <lpage>26</lpage>
          <issue-id pub-id-type="doi">10.2188/jea.JE20160141</issue-id>
        </element-citation>
      </ref>
      <ref id="B10">
        <label>10</label>
        <mixed-citation>10. Jayedi A, Rashidy-Pour A, Khorshidi M, Shab-Bidar S. Body Mass Index, Abdominal Adiposity, Weight Gain and Risk of Developing Hypertension: A Systematic Review and Dose-response Meta-analysis of More Than 2.3 Million Participants. Obes Rev. 2018;19(5):654-67. doi: 10.1111/obr.12656.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jayedi</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Rashidy-Pour</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Khorshidi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Shab-Bidar</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Body Mass Index, Abdominal Adiposity, Weight Gain and Risk of Developing Hypertension: A Systematic Review and Dose-response Meta-analysis of More Than 2.3 Million Participants</article-title>
          <source> Obes Rev </source>
          <year>2018</year>
          <volume>19</volume>
          <issue>5</issue>
          <fpage>654</fpage>
          <lpage>667</lpage>
          <issue-id pub-id-type="doi">10.1111/obr.12656</issue-id>
        </element-citation>
      </ref>
      <ref id="B11">
        <label>11</label>
        <mixed-citation>11. Redwine KM, Acosta AA, Poffenbarger T, Portman RJ, Samuels J. Development of Hypertension in Adolescents with Pre-hypertension. J Pediatr. 2012;160(1):98-103. doi: 10.1016/j.jpeds.2011.07.010.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Redwine</surname>
              <given-names>KM</given-names>
            </name>
            <name>
              <surname>Acosta</surname>
              <given-names>AA</given-names>
            </name>
            <name>
              <surname>Poffenbarger</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Portman</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Samuels</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Development of Hypertension in Adolescents with Pre-hypertension</article-title>
          <source> J Pediatr </source>
          <year>2012</year>
          <volume>160</volume>
          <issue>1</issue>
          <fpage>98</fpage>
          <lpage>103</lpage>
          <issue-id pub-id-type="doi">10.1016/j.jpeds.2011.07.010</issue-id>
        </element-citation>
      </ref>
      <ref id="B12">
        <label>12</label>
        <mixed-citation>12. Barrington DS, James SA. Receipt of Public Assistance During Childhood and Hypertension Risk in Adulthood. Ann Epidemiol. 2017;27(2):108-14. doi: 10.1016/j.annepidem.2016.11.012.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Barrington</surname>
              <given-names>DS</given-names>
            </name>
            <name>
              <surname>James</surname>
              <given-names>SA</given-names>
            </name>
          </person-group>
          <article-title>Receipt of Public Assistance During Childhood and Hypertension Risk in Adulthood</article-title>
          <source> Ann Epidemiol </source>
          <year>2017</year>
          <volume>27</volume>
          <issue>2</issue>
          <fpage>108</fpage>
          <lpage>114</lpage>
          <issue-id pub-id-type="doi">10.1016/j.annepidem.2016.11.012</issue-id>
        </element-citation>
      </ref>
      <ref id="B13">
        <label>13</label>
        <mixed-citation>13. Sui X, Sarzynski MA, Lee DC, Lavie CJ, Zhang J, Kokkinos PF, et al. Longitudinal Patterns of Cardiorespiratory Fitness Predict the Development of Hypertension Among Men and Women. Am J Med. 2017;130(4):469-76. doi: 10.1016/j.amjmed.2016.11.017.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sui</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Sarzynski</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>DC</given-names>
            </name>
            <name>
              <surname>Lavie</surname>
              <given-names>CJ</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Kokkinos</surname>
              <given-names>PF</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Longitudinal Patterns of Cardiorespiratory Fitness Predict the Development of Hypertension Among Men and Women</article-title>
          <source> Am J Med </source>
          <year>2017</year>
          <volume>130</volume>
          <issue>4</issue>
          <fpage>469</fpage>
          <lpage>476</lpage>
          <issue-id pub-id-type="doi">10.1016/j.amjmed.2016.11.017</issue-id>
        </element-citation>
      </ref>
      <ref id="B14">
        <label>14</label>
        <mixed-citation>14. Genovesi S, Giussani M, Orlando A, Battaglino MG, Nava E, Parati G. Prevention of Cardiovascular Diseases in Children and Adolescents. High Blood Press Cardiovasc Prev. 2019;26(3):191-7. doi: 10.1007/s40292-019-00316-6.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Genovesi</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Giussani</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Orlando</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Battaglino</surname>
              <given-names>MG</given-names>
            </name>
            <name>
              <surname>Nava</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Parati</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Prevention of Cardiovascular Diseases in Children and Adolescents</article-title>
          <source> High Blood Press Cardiovasc Prev </source>
          <year>2019</year>
          <volume>26</volume>
          <issue>3</issue>
          <fpage>191</fpage>
          <lpage>197</lpage>
          <issue-id pub-id-type="doi">10.1007/s40292-019-00316-6</issue-id>
        </element-citation>
      </ref>
      <ref id="B15">
        <label>15</label>
        <mixed-citation>15. Viazzi F, Antolini L, Giussani M, Brambilla P, Galbiati S, Mastriani S, et al. Serum Uric acid and Blood Pressure in Children at Cardiovascular Risk. Pediatrics. 2013;132(1):93-9. doi: 10.1542/peds.2013-0047.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Viazzi</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Antolini</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Giussani</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Brambilla</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Galbiati</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Mastriani</surname>
              <given-names>S</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Serum Uric acid and Blood Pressure in Children at Cardiovascular Risk</article-title>
          <source> Pediatrics </source>
          <year>2013</year>
          <volume>132</volume>
          <issue>1</issue>
          <fpage>93</fpage>
          <lpage>99</lpage>
          <issue-id pub-id-type="doi">10.1542/peds.2013-0047</issue-id>
        </element-citation>
      </ref>
      <ref id="B16">
        <label>16</label>
        <mixed-citation>16. Nathan BM, Moran A. Metabolic Complications of Obesity in Childhood and Adolescence: More than Just Diabetes. Curr Opin Endocrinol Diabetes Obes. 2008;15(1):21-9. doi: 10.1097/MED.0b013e3282f43d19.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nathan</surname>
              <given-names>BM</given-names>
            </name>
            <name>
              <surname>Moran</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Metabolic Complications of Obesity in Childhood and Adolescence: More than Just Diabetes</article-title>
          <source> Curr Opin Endocrinol Diabetes Obes </source>
          <year>2008</year>
          <volume>15</volume>
          <issue>1</issue>
          <fpage>21</fpage>
          <lpage>29</lpage>
          <issue-id pub-id-type="doi">10.1097/MED.0b013e3282f43d19</issue-id>
        </element-citation>
      </ref>
      <ref id="B17">
        <label>17</label>
        <mixed-citation>17. Lacruz ME, Kluttig A, Hartwig S, L&#246;er M, Tiller D, Greiser KH, et al. Prevalence and Incidence of Hypertension in the General Adult Population: Results of the CARLA-Cohort Study. Medicine (Baltimore). 2015;94(22):e952. doi: 10.1097/MD.0000000000000952.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lacruz</surname>
              <given-names>ME</given-names>
            </name>
            <name>
              <surname>Kluttig</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Hartwig</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>L&#246;er</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Tiller</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Greiser</surname>
              <given-names>KH</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Prevalence and Incidence of Hypertension in the General Adult Population: Results of the CARLA-Cohort Study</article-title>
          <source> Medicine (Baltimore) </source>
          <year>2015</year>
          <volume>94</volume>
          <issue>22</issue>
          <elocation-id>e952</elocation-id>
          <issue-id pub-id-type="doi">10.1097/MD.0000000000000952</issue-id>
        </element-citation>
      </ref>
      <ref id="B18">
        <label>18</label>
        <mixed-citation>18. Flynn JT, Kaelber DC, Baker-Smith CM, Blowey D, Carroll AE, Daniels SR, et al. Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents. Pediatrics. 2017;140(3):e20171904. doi: 10.1542/peds.2017-1904.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Flynn</surname>
              <given-names>JT</given-names>
            </name>
            <name>
              <surname>Kaelber</surname>
              <given-names>DC</given-names>
            </name>
            <name>
              <surname>Baker-Smith</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Blowey</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Carroll</surname>
              <given-names>AE</given-names>
            </name>
            <name>
              <surname>Daniels</surname>
              <given-names>SR</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents</article-title>
          <source> Pediatrics </source>
          <year>2017</year>
          <volume>140</volume>
          <issue>3</issue>
          <elocation-id>e20171904</elocation-id>
          <issue-id pub-id-type="doi">10.1542/peds.2017-1904</issue-id>
        </element-citation>
      </ref>
      <ref id="B19">
        <label>19</label>
        <mixed-citation>19. Fern&#225;ndez JR, Redden DT, Pietrobelli A, Allison DB. Waist Circumference Percentiles in Nationally Representative Samples of African-American, European-American, and Mexican-American Children and Adolescents. J Pediatr. 2004;145(4):439-44. doi: 10.1016/j.jpeds.2004.06.044.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fern&#225;ndez</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Redden</surname>
              <given-names>DT</given-names>
            </name>
            <name>
              <surname>Pietrobelli</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Allison</surname>
              <given-names>DB</given-names>
            </name>
          </person-group>
          <article-title>Waist Circumference Percentiles in Nationally Representative Samples of African-American, European-American, and Mexican-American Children and Adolescents</article-title>
          <source> J Pediatr </source>
          <year>2004</year>
          <volume>145</volume>
          <issue>4</issue>
          <fpage>439</fpage>
          <lpage>444</lpage>
          <issue-id pub-id-type="doi">10.1016/j.jpeds.2004.06.044</issue-id>
        </element-citation>
      </ref>
      <ref id="B20">
        <label>20</label>
        <mixed-citation>20. World Health Organization. Child Growth Reference Data for 5-19 Years Standards. Geneva: WHO Library; 2007.</mixed-citation>
        <element-citation publication-type="report">
          <person-group person-group-type="author">
            <collab>World Health Organization</collab>
          </person-group>
          <source> Child Growth Reference Data for 5-19 Years Standards </source>
          <publisher-loc>Geneva</publisher-loc>
          <publisher-name>WHO Library</publisher-name>
          <year>2007</year>
        </element-citation>
      </ref>
      <ref id="B21">
        <label>21</label>
        <mixed-citation>21. Heyward V, Stolarczyk L. Avalia&#231;&#227;o da Composi&#231;&#227;o Corporal Aplicada. S&#227;o Paulo: Manole; 2000.</mixed-citation>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Heyward</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Stolarczyk</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <source> Avalia&#231;&#227;o da Composi&#231;&#227;o Corporal Aplicada </source>
          <publisher-loc>S&#227;o Paulo</publisher-loc>
          <publisher-name>Manole</publisher-name>
          <year>2000</year>
        </element-citation>
      </ref>
      <ref id="B22">
        <label>22</label>
        <mixed-citation>22. Lohman TG. The Use of Skinfold to Estimate Body Fatness on Children and Youth. J Phys Ed. 1987;58(9):98&#8211;102. doi: 10.1080/07303084.1987.10604383.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lohman</surname>
              <given-names>TG</given-names>
            </name>
          </person-group>
          <article-title>The Use of Skinfold to Estimate Body Fatness on Children and Youth</article-title>
          <source> J Phys Ed </source>
          <year>1987</year>
          <volume>58</volume>
          <issue>9</issue>
          <fpage>98</fpage>
          <lpage>102</lpage>
          <issue-id pub-id-type="doi">10.1080/07303084.1987.10604383</issue-id>
        </element-citation>
      </ref>
      <ref id="B23">
        <label>23</label>
        <mixed-citation>23. Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents; National Heart, Lung, and Blood Institute. Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents: Summary Report. Pediatrics. 2011;128(Suppl 5):213-56. doi: 10.1542/peds.2009-2107C.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <collab>Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents</collab>
            <collab>National Heart, Lung, and Blood Institute</collab>
          </person-group>
          <article-title>Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents: Summary Report</article-title>
          <source> Pediatrics </source>
          <year>2011</year>
          <volume>128</volume>
          <supplement>Suppl 5</supplement>
          <fpage>213</fpage>
          <lpage>256</lpage>
          <issue-id pub-id-type="doi">10.1542/peds.2009-2107C</issue-id>
        </element-citation>
      </ref>
      <ref id="B24">
        <label>24</label>
        <mixed-citation>24. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the Concentration of Low-density Lipoprotein Cholesterol in Plasma, Without Use of the Preparative Ultracentrifuge. Clinical Chemistry. 1972;18(6):499&#8211;502.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Friedewald</surname>
              <given-names>WT</given-names>
            </name>
            <name>
              <surname>Levy</surname>
              <given-names>RI</given-names>
            </name>
            <name>
              <surname>Fredrickson</surname>
              <given-names>DS</given-names>
            </name>
          </person-group>
          <article-title>Estimation of the Concentration of Low-density Lipoprotein Cholesterol in Plasma, Without Use of the Preparative Ultracentrifuge</article-title>
          <source> Clinical Chemistry </source>
          <year>1972</year>
          <volume>18</volume>
          <issue>6</issue>
          <fpage>499</fpage>
          <lpage>502</lpage>
        </element-citation>
      </ref>
      <ref id="B25">
        <label>25</label>
        <mixed-citation>25. American Diabetes Association. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2018. Diabetes Care. 2018;41(Suppl 1):13-27. doi: 10.2337/dc18-S002.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <collab>American Diabetes Association</collab>
          </person-group>
          <article-title>Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2018</article-title>
          <source> Diabetes Care </source>
          <year>2018</year>
          <volume>41</volume>
          <supplement>Suppl 1</supplement>
          <fpage>13</fpage>
          <lpage>27</lpage>
          <issue-id pub-id-type="doi">10.2337/dc18-S002</issue-id>
        </element-citation>
      </ref>
      <ref id="B26">
        <label>26</label>
        <mixed-citation>26. Todendi PF, Klinger EI, Geraldo ACR, Brixner L, Reuter CP, Lindenau JDR, et al. Genetic Risk Score Based on Fat Mass and Obesity-associated, Transmembrane Protein 18 and Fibronectin Type III Domain Containing 5 Polymorphisms is Associated with Anthropometric Characteristics in South Brazilian Children and Adolescents. Br J Nutr. 2019;121(1):93-9. doi: 10.1017/S0007114518002738.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Todendi</surname>
              <given-names>PF</given-names>
            </name>
            <name>
              <surname>Klinger</surname>
              <given-names>EI</given-names>
            </name>
            <name>
              <surname>Geraldo</surname>
              <given-names>ACR</given-names>
            </name>
            <name>
              <surname>Brixner</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Reuter</surname>
              <given-names>CP</given-names>
            </name>
            <name>
              <surname>Lindenau</surname>
              <given-names>JDR</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Genetic Risk Score Based on Fat Mass and Obesity-associated, Transmembrane Protein 18 and Fibronectin Type III Domain Containing 5 Polymorphisms is Associated with Anthropometric Characteristics in South Brazilian Children and Adolescents</article-title>
          <source> Br J Nutr </source>
          <year>2019</year>
          <volume>121</volume>
          <issue>1</issue>
          <fpage>93</fpage>
          <lpage>99</lpage>
          <issue-id pub-id-type="doi">10.1017/S0007114518002738</issue-id>
        </element-citation>
      </ref>
      <ref id="B27">
        <label>27</label>
        <mixed-citation>27. Reuter CP, Burgos MS, Bernhard JC, Tornquist D, Klinger EI, Borges TS, et al. Association Between Overweight and Obesity in Schoolchildren with rs9939609 Polymorphism (FTO) and Family History for Obesity. J Pediatr (Rio J). 2016;92(5):493-8. doi: 10.1016/j.jped.2015.11.005.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Reuter</surname>
              <given-names>CP</given-names>
            </name>
            <name>
              <surname>Burgos</surname>
              <given-names>MS</given-names>
            </name>
            <name>
              <surname>Bernhard</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Tornquist</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Klinger</surname>
              <given-names>EI</given-names>
            </name>
            <name>
              <surname>Borges</surname>
              <given-names>TS</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Association Between Overweight and Obesity in Schoolchildren with rs9939609 Polymorphism (FTO) and Family History for Obesity</article-title>
          <source> J Pediatr (Rio J) </source>
          <year>2016</year>
          <volume>92</volume>
          <issue>5</issue>
          <fpage>493</fpage>
          <lpage>498</lpage>
          <issue-id pub-id-type="doi">10.1016/j.jped.2015.11.005</issue-id>
        </element-citation>
      </ref>
      <ref id="B28">
        <label>28</label>
        <mixed-citation>28. Projeto Esporte Brasil. Manual de Aplica&#231;&#227;o De Medidas e Testes, Normas e Crit&#233;rios de Avalia&#231;&#227;o. Porto Alegre: PROESP; 2009.</mixed-citation>
        <element-citation publication-type="report">
          <person-group person-group-type="author">
            <collab>Projeto Esporte Brasil</collab>
          </person-group>
          <source> Manual de Aplica&#231;&#227;o De Medidas e Testes, Normas e Crit&#233;rios de Avalia&#231;&#227;o </source>
          <publisher-loc>Porto Alegre</publisher-loc>
          <publisher-name>PROESP</publisher-name>
          <year>2009</year>
        </element-citation>
      </ref>
      <ref id="B29">
        <label>29</label>
        <mixed-citation>29. Projeto Esporte Brasil. Manual de Aplica&#231;&#227;o de Medidas e Testes, Normas e Crit&#233;rios de Avalia&#231;&#227;o. Porto Alegre: PROESP; 2012.</mixed-citation>
        <element-citation publication-type="report">
          <person-group person-group-type="author">
            <collab>Projeto Esporte Brasil</collab>
          </person-group>
          <source> Manual de Aplica&#231;&#227;o de Medidas e Testes, Normas e Crit&#233;rios de Avalia&#231;&#227;o </source>
          <publisher-loc>Porto Alegre</publisher-loc>
          <publisher-name>PROESP</publisher-name>
          <year>2012</year>
        </element-citation>
      </ref>
      <ref id="B30">
        <label>30</label>
        <mixed-citation>30. Gaya AR, Gaya A, Pedretti A, Mello J. Projeto Esporte Brasil: Manual de Medidas, Testes e Avalia&#231;&#245;es. Porto Alegre: UFRGS/ESEFID; 2021.</mixed-citation>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Gaya</surname>
              <given-names>AR</given-names>
            </name>
            <name>
              <surname>Gaya</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Pedretti</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Mello</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <source> Projeto Esporte Brasil: Manual de Medidas, Testes e Avalia&#231;&#245;es </source>
          <publisher-loc>Porto Alegre</publisher-loc>
          <publisher-name>UFRGS/ESEFID</publisher-name>
          <year>2021</year>
        </element-citation>
      </ref>
      <ref id="B31">
        <label>31</label>
        <mixed-citation>31. W&#252;hl E. Hypertension in Childhood Obesity. Acta Paediatr. 2019;108(1):37-43. doi: 10.1111/apa.14551.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>W&#252;hl</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>Hypertension in Childhood Obesity</article-title>
          <source> Acta Paediatr </source>
          <year>2019</year>
          <volume>108</volume>
          <issue>1</issue>
          <fpage>37</fpage>
          <lpage>43</lpage>
          <issue-id pub-id-type="doi">10.1111/apa.14551</issue-id>
        </element-citation>
      </ref>
      <ref id="B32">
        <label>32</label>
        <mixed-citation>32. Bloch KV, Klein CH, Szklo M, Kuschnir MC, Abreu GA, Barufaldi LA, et al. ERICA: Prevalences of Hypertension and Obesity in Brazilian Adolescents. Rev Saude Publica. 2016;50 (Suppl 1):9. doi: 10.1590/S01518-8787.2016050006685.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bloch</surname>
              <given-names>KV</given-names>
            </name>
            <name>
              <surname>Klein</surname>
              <given-names>CH</given-names>
            </name>
            <name>
              <surname>Szklo</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kuschnir</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Abreu</surname>
              <given-names>GA</given-names>
            </name>
            <name>
              <surname>Barufaldi</surname>
              <given-names>LA</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>ERICA: Prevalences of Hypertension and Obesity in Brazilian Adolescents</article-title>
          <source> Rev Saude Publica </source>
          <year>2016</year>
          <volume>50</volume>
          <supplement>Suppl 1</supplement>
          <size units="pages">9</size>
          <pub-id pub-id-type="doi">10.1590/S01518-8787.2016050006685</pub-id>
        </element-citation>
      </ref>
      <ref id="B33">
        <label>33</label>
        <mixed-citation>33. Zhao Y, Wang L, Xue H, Wang H, Wang Y. Fast Food Consumption and its Associations with Obesity and Hypertension Among Children: Results from the Baseline Data of the Childhood Obesity Study in China Mega-cities. BMC Public Health. 2017;17(1):933. doi: 10.1186/s12889-017-4952-x.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhao</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Xue</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
          <article-title>Fast Food Consumption and its Associations with Obesity and Hypertension Among Children: Results from the Baseline Data of the Childhood Obesity Study in China Mega-cities</article-title>
          <source> BMC Public Health </source>
          <year>2017</year>
          <volume>17</volume>
          <issue>1</issue>
          <size units="pages">933</size>
          <issue-id pub-id-type="doi">10.1186/s12889-017-4952-x</issue-id>
        </element-citation>
      </ref>
      <ref id="B34">
        <label>34</label>
        <mixed-citation>34. Pereira FEF, Teixeira FDC, Kac G, Soares EA, Ribeiro BG. Overweight and Obesity Associated with High Blood Pressure: A Cross-sectional Study in Brazilian Students. Rev Esc Enferm USP. 2020;54:e03654. doi: 10.1590/S1980-220X2019036203654.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pereira</surname>
              <given-names>FEF</given-names>
            </name>
            <name>
              <surname>Teixeira</surname>
              <given-names>FDC</given-names>
            </name>
            <name>
              <surname>Kac</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Soares</surname>
              <given-names>EA</given-names>
            </name>
            <name>
              <surname>Ribeiro</surname>
              <given-names>BG</given-names>
            </name>
          </person-group>
          <article-title>Overweight and Obesity Associated with High Blood Pressure: A Cross-sectional Study in Brazilian Students</article-title>
          <source> Rev Esc Enferm USP </source>
          <year>2020</year>
          <volume>54</volume>
          <elocation-id>e03654</elocation-id>
          <issue-id pub-id-type="doi">10.1590/S1980-220X2019036203654</issue-id>
        </element-citation>
      </ref>
      <ref id="B35">
        <label>35</label>
        <mixed-citation>35. Zhang CX, Shi JD, Huang HY, Feng LM, Ma J. Nutritional Status and its Relationship with Blood Pressure Among Children and Adolescents in South China. Eur J Pediatr. 2012;171(7):1073-9. doi: 10.1007/s00431-012-1684-x.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhang</surname>
              <given-names>CX</given-names>
            </name>
            <name>
              <surname>Shi</surname>
              <given-names>JD</given-names>
            </name>
            <name>
              <surname>Huang</surname>
              <given-names>HY</given-names>
            </name>
            <name>
              <surname>Feng</surname>
              <given-names>LM</given-names>
            </name>
            <name>
              <surname>Ma</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Nutritional Status and its Relationship with Blood Pressure Among Children and Adolescents in South China</article-title>
          <source> Eur J Pediatr </source>
          <year>2012</year>
          <volume>171</volume>
          <issue>7</issue>
          <fpage>1073</fpage>
          <lpage>1079</lpage>
          <issue-id pub-id-type="doi">10.1007/s00431-012-1684-x</issue-id>
        </element-citation>
      </ref>
      <ref id="B36">
        <label>36</label>
        <mixed-citation>36. Cruz NRC, Cardoso PC, Frossard TNSV, Ferreira FO, Brener S, Gomides AFF, et al. Waist Circumference as High Blood Pressure Predictor in School Age Children. Cien Saude Colet. 2019;24(5):1885-93. doi: 10.1590/1413-81232018245.18012017.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cruz</surname>
              <given-names>NRC</given-names>
            </name>
            <name>
              <surname>Cardoso</surname>
              <given-names>PC</given-names>
            </name>
            <name>
              <surname>Frossard</surname>
              <given-names>TNSV</given-names>
            </name>
            <name>
              <surname>Ferreira</surname>
              <given-names>FO</given-names>
            </name>
            <name>
              <surname>Brener</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Gomides</surname>
              <given-names>AFF</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Waist Circumference as High Blood Pressure Predictor in School Age Children</article-title>
          <source> Cien Saude Colet </source>
          <year>2019</year>
          <volume>24</volume>
          <issue>5</issue>
          <fpage>1885</fpage>
          <lpage>1893</lpage>
          <issue-id pub-id-type="doi">10.1590/1413-81232018245.18012017</issue-id>
        </element-citation>
      </ref>
      <ref id="B37">
        <label>37</label>
        <mixed-citation>37. Andrade GN, Matoso LF, Miranda JWB, Lima TF, Gazzinelli A, Vieira EW. Anthropometric Indicators Associated with High Blood Pressure in Children Living in Urban and Rural Areas. Rev Lat Am Enfermagem. 2019;27:e3150. doi: 10.1590/1518-8345.2760-3150.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Andrade</surname>
              <given-names>GN</given-names>
            </name>
            <name>
              <surname>Matoso</surname>
              <given-names>LF</given-names>
            </name>
            <name>
              <surname>Miranda</surname>
              <given-names>JWB</given-names>
            </name>
            <name>
              <surname>Lima</surname>
              <given-names>TF</given-names>
            </name>
            <name>
              <surname>Gazzinelli</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Vieira</surname>
              <given-names>EW</given-names>
            </name>
          </person-group>
          <article-title>Anthropometric Indicators Associated with High Blood Pressure in Children Living in Urban and Rural Areas</article-title>
          <source> Rev Lat Am Enfermagem </source>
          <year>2019</year>
          <volume>27</volume>
          <elocation-id>e3150</elocation-id>
          <issue-id pub-id-type="doi">10.1590/1518-8345.2760-3150</issue-id>
        </element-citation>
      </ref>
      <ref id="B38">
        <label>38</label>
        <mixed-citation>38. Dong B, Wang Z, Yang Y, Wang HJ, Ma J. Intensified Association Between Waist Circumference and Hypertension in Abdominally Overweight Children. Obes Res Clin Pract. 2016;10(1):24-32. doi: 10.1016/j.orcp.2015.04.002.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dong</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>HJ</given-names>
            </name>
            <name>
              <surname>Ma</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Intensified Association Between Waist Circumference and Hypertension in Abdominally Overweight Children</article-title>
          <source> Obes Res Clin Pract </source>
          <year>2016</year>
          <volume>10</volume>
          <issue>1</issue>
          <fpage>24</fpage>
          <lpage>32</lpage>
          <issue-id pub-id-type="doi">10.1016/j.orcp.2015.04.002</issue-id>
        </element-citation>
      </ref>
      <ref id="B39">
        <label>39</label>
        <mixed-citation>39. Christofaro DGD, Farah BQ, Vanderlei LCM, Delfino LD, Tebar WR, Barros MVG, et al. Analysis of Different Anthropometric Indicators in the Detection of High Blood Pressure in School Adolescents: A Cross-sectional Study with 8295 Adolescents. Braz J Phys Ther. 2018;22(1):49-54. doi: 10.1016/j.bjpt.2017.10.007.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Christofaro</surname>
              <given-names>DGD</given-names>
            </name>
            <name>
              <surname>Farah</surname>
              <given-names>BQ</given-names>
            </name>
            <name>
              <surname>Vanderlei</surname>
              <given-names>LCM</given-names>
            </name>
            <name>
              <surname>Delfino</surname>
              <given-names>LD</given-names>
            </name>
            <name>
              <surname>Tebar</surname>
              <given-names>WR</given-names>
            </name>
            <name>
              <surname>Barros</surname>
              <given-names>MVG</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Analysis of Different Anthropometric Indicators in the Detection of High Blood Pressure in School Adolescents: A Cross-sectional Study with 8295 Adolescents</article-title>
          <source> Braz J Phys Ther </source>
          <year>2018</year>
          <volume>22</volume>
          <issue>1</issue>
          <fpage>49</fpage>
          <lpage>54</lpage>
          <issue-id pub-id-type="doi">10.1016/j.bjpt.2017.10.007</issue-id>
        </element-citation>
      </ref>
      <ref id="B40">
        <label>40</label>
        <mixed-citation>40. Pazin DC, Rosaneli CF, Olandoski M, Oliveira ERN, Baena CP, Figueredo AS, et al. Waist Circumference is Associated with Blood Pressure in Children with Normal Body Mass Index: A Cross-Sectional Analysis of 3,417 School Children. Arq Bras Cardiol. 2017;109(6):509-15. doi: 10.5935/abc.20170162.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pazin</surname>
              <given-names>DC</given-names>
            </name>
            <name>
              <surname>Rosaneli</surname>
              <given-names>CF</given-names>
            </name>
            <name>
              <surname>Olandoski</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Oliveira</surname>
              <given-names>ERN</given-names>
            </name>
            <name>
              <surname>Baena</surname>
              <given-names>CP</given-names>
            </name>
            <name>
              <surname>Figueredo</surname>
              <given-names>AS</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Waist Circumference is Associated with Blood Pressure in Children with Normal Body Mass Index: A Cross-Sectional Analysis of 3,417 School Children</article-title>
          <source> Arq Bras Cardiol </source>
          <year>2017</year>
          <volume>109</volume>
          <issue>6</issue>
          <fpage>509</fpage>
          <lpage>515</lpage>
          <issue-id pub-id-type="doi">10.5935/abc.20170162</issue-id>
        </element-citation>
      </ref>
      <ref id="B41">
        <label>41</label>
        <mixed-citation>41. Xu RY, Zhou YQ, Zhang XM, Wan YP, Gao X. Body Mass Index, Waist Circumference, Body Fat Mass, and Risk of Developing Hypertension in Normal-weight Children and Adolescents. Nutr Metab Cardiovasc Dis. 2018;28(10):1061-6. doi: 10.1016/j.numecd.2018.05.015.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Xu</surname>
              <given-names>RY</given-names>
            </name>
            <name>
              <surname>Zhou</surname>
              <given-names>YQ</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>XM</given-names>
            </name>
            <name>
              <surname>Wan</surname>
              <given-names>YP</given-names>
            </name>
            <name>
              <surname>Gao</surname>
              <given-names>X</given-names>
            </name>
          </person-group>
          <article-title>Body Mass Index, Waist Circumference, Body Fat Mass, and Risk of Developing Hypertension in Normal-weight Children and Adolescents</article-title>
          <source> Nutr Metab Cardiovasc Dis </source>
          <year>2018</year>
          <volume>28</volume>
          <issue>10</issue>
          <fpage>1061</fpage>
          <lpage>1066</lpage>
          <issue-id pub-id-type="doi">10.1016/j.numecd.2018.05.015</issue-id>
        </element-citation>
      </ref>
      <ref id="B42">
        <label>42</label>
        <mixed-citation>42. Bogaert YE, Linas S. The Role of Obesity in the Pathogenesis of Hypertension. Nat Clin Pract Nephrol. 2009;5(2):101-11. doi: 10.1038/ncpneph1022.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bogaert</surname>
              <given-names>YE</given-names>
            </name>
            <name>
              <surname>Linas</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>The Role of Obesity in the Pathogenesis of Hypertension</article-title>
          <source> Nat Clin Pract Nephrol </source>
          <year>2009</year>
          <volume>5</volume>
          <issue>2</issue>
          <fpage>101</fpage>
          <lpage>111</lpage>
          <issue-id pub-id-type="doi">10.1038/ncpneph1022</issue-id>
        </element-citation>
      </ref>
      <ref id="B43">
        <label>43</label>
        <mixed-citation>43. Kelishadi R, Mirmoghtadaee P, Najafi H, Keikha M. Systematic Review on the Association of Abdominal Obesity in Children and Adolescents with Cardio-metabolic Risk Factors. J Res Med Sci. 2015;20(3):294&#8211;307.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kelishadi</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Mirmoghtadaee</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Najafi</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Keikha</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Systematic Review on the Association of Abdominal Obesity in Children and Adolescents with Cardio-metabolic Risk Factors</article-title>
          <source> J Res Med Sci </source>
          <year>2015</year>
          <volume>20</volume>
          <issue>3</issue>
          <fpage>294</fpage>
          <lpage>307</lpage>
        </element-citation>
      </ref>
      <ref id="B44">
        <label>44</label>
        <mixed-citation>44. Ma C, Wang R, Liu Y, Lu Q, Lu N, Tian Y, et al. Performance of Obesity Indices for Screening Elevated Blood Pressure in Pediatric Population: Systematic Review and Meta-analysis. Medicine (Baltimore). 2016;95(39):e4811. doi: 10.1097/MD.0000000000004811.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ma</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Lu</surname>
              <given-names>Q</given-names>
            </name>
            <name>
              <surname>Lu</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Tian</surname>
              <given-names>Y</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Performance of Obesity Indices for Screening Elevated Blood Pressure in Pediatric Population: Systematic Review and Meta-analysis</article-title>
          <source> Medicine (Baltimore) </source>
          <year>2016</year>
          <volume>95</volume>
          <issue>39</issue>
          <elocation-id>e4811</elocation-id>
          <issue-id pub-id-type="doi">10.1097/MD.0000000000004811</issue-id>
        </element-citation>
      </ref>
      <ref id="B45">
        <label>45</label>
        <mixed-citation>45. Seo DC, Choe S, Torabi MR. Is Waist Circumference &#8805;102/88cm Better Than Body Mass Index &#8805;30 to Predict Hypertension and Diabetes Development Regardless of Gender, Age Group, and Race/Ethnicity? Meta-analysis. Prev Med. 2017;97:100-8. doi: 10.1016/j.ypmed.2017.01.012.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Seo</surname>
              <given-names>DC</given-names>
            </name>
            <name>
              <surname>Choe</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Torabi</surname>
              <given-names>MR</given-names>
            </name>
          </person-group>
          <article-title>Is Waist Circumference &#8805;102/88cm Better Than Body Mass Index &#8805;30 to Predict Hypertension and Diabetes Development Regardless of Gender, Age Group, and Race/Ethnicity? Meta-analysis</article-title>
          <source> Prev Med </source>
          <year>2017</year>
          <volume>97</volume>
          <fpage>100</fpage>
          <lpage>108</lpage>
          <issue-id pub-id-type="doi">10.1016/j.ypmed.2017.01.012</issue-id>
        </element-citation>
      </ref>
      <ref id="B46">
        <label>46</label>
        <mixed-citation>46. Qiong W. Analysis of the relationship between body fat content and blood pressure of high school students in Wuhan. Chinese Health at School. 2008;29(5):476&#8211;7.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Qiong</surname>
              <given-names>W</given-names>
            </name>
          </person-group>
          <article-title>Analysis of the relationship between body fat content and blood pressure of high school students in Wuhan</article-title>
          <source> Chinese Health at School </source>
          <year>2008</year>
          <volume>29</volume>
          <issue>5</issue>
          <fpage>476</fpage>
          <lpage>477</lpage>
        </element-citation>
      </ref>
      <ref id="B47">
        <label>47</label>
        <mixed-citation>47. Tao RW, Wan YH, Zhang H, Wang YF, Wang B, Xu L, et al. Relationship between hypertension and percentage of body fat, in children of Anhui province. 2016;37(2):178-82. doi: 10.3760/cma.j.issn.0254-6450.2016.02.005.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tao</surname>
              <given-names>RW</given-names>
            </name>
            <name>
              <surname>Wan</surname>
              <given-names>YH</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>YF</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Xu</surname>
              <given-names>L</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <source> Relationship between hypertension and percentage of body fat, in children of Anhui province </source>
          <year>2016</year>
          <volume>37</volume>
          <issue>2</issue>
          <fpage>178</fpage>
          <lpage>182</lpage>
          <issue-id pub-id-type="doi">10.3760/cma.j.issn.0254-6450.2016.02.005.</issue-id>
        </element-citation>
      </ref>
      <ref id="B48">
        <label>48</label>
        <mixed-citation>48. Markus MR, Ittermann T, Baumeister SE, Troitzsch P, Schipf S, Lorbeer R, et al. Long-term Changes in Body Weight are Associated with Changes in Blood Pressure Levels. Nutr Metab Cardiovasc Dis. 2015;25(3):305-11. doi: 10.1016/j.numecd.2014.10.011.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Markus</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Ittermann</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Baumeister</surname>
              <given-names>SE</given-names>
            </name>
            <name>
              <surname>Troitzsch</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Schipf</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Lorbeer</surname>
              <given-names>R</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Long-term Changes in Body Weight are Associated with Changes in Blood Pressure Levels</article-title>
          <source> Nutr Metab Cardiovasc Dis </source>
          <year>2015</year>
          <volume>25</volume>
          <issue>3</issue>
          <fpage>305</fpage>
          <lpage>311</lpage>
          <issue-id pub-id-type="doi">10.1016/j.numecd.2014.10.011</issue-id>
        </element-citation>
      </ref>
      <ref id="B49">
        <label>49</label>
        <mixed-citation>49. Sociedade Brasileira de Cardiologia. VII Diretriz Brasileira de Hipertens&#227;o Arterial. Arq Bras Cardiol. 2016;40(4):306.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <collab>Sociedade Brasileira de Cardiologia</collab>
          </person-group>
          <article-title>VII Diretriz Brasileira de Hipertens&#227;o Arterial</article-title>
          <source> Arq Bras Cardiol </source>
          <year>2016</year>
          <volume>40</volume>
          <issue>4</issue>
          <size units="pages">306</size>
        </element-citation>
      </ref>
      <ref id="B50">
        <label>50</label>
        <mixed-citation>50. Polito LFT, Zanetti MC, Sanches IC, Montenegro CGSP, Brand&#227;o MRF, Junior AJF. Obesidade e seus Fatores Associados. Propostas para Promo&#231;&#227;o da Sa&#250;de a partir do Exerc&#237;cio F&#237;sico e da Ader&#234;ncia a ele Associada. CREF4: S&#227;o Paulo; 2018.</mixed-citation>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Polito</surname>
              <given-names>LFT</given-names>
            </name>
            <name>
              <surname>Zanetti</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Sanches</surname>
              <given-names>IC</given-names>
            </name>
            <name>
              <surname>Montenegro</surname>
              <given-names>CGSP</given-names>
            </name>
            <name>
              <surname>Brand&#227;o</surname>
              <given-names>MRF</given-names>
            </name>
            <name>
              <surname>Junior</surname>
              <given-names>AJF</given-names>
            </name>
          </person-group>
          <source> Obesidade e seus Fatores Associados. Propostas para Promo&#231;&#227;o da Sa&#250;de a partir do Exerc&#237;cio F&#237;sico e da Ader&#234;ncia a ele Associada </source>
          <publisher-name>CREF4</publisher-name>
          <publisher-loc>S&#227;o Paulo</publisher-loc>
          <year>2018</year>
        </element-citation>
      </ref>
      <ref id="B51">
        <label>51</label>
        <mixed-citation>51. Ittermann T, Werner N, Lieb W, Merz B, N&#246;thlings U, Kluttig A, et al. Changes in Fat Mass and Fat-free-mass are Associated with Incident Hypertension in Four Population-based Studies from Germany. Int J Cardiol. 2019;274:372-7. doi: 10.1016/j.ijcard.2018.09.035.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ittermann</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Werner</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Lieb</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Merz</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>N&#246;thlings</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Kluttig</surname>
              <given-names>A</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Changes in Fat Mass and Fat-free-mass are Associated with Incident Hypertension in Four Population-based Studies from Germany</article-title>
          <source> Int J Cardiol </source>
          <year>2019</year>
          <volume>274</volume>
          <fpage>372</fpage>
          <lpage>377</lpage>
          <issue-id pub-id-type="doi">10.1016/j.ijcard.2018.09.035</issue-id>
        </element-citation>
      </ref>
      <ref id="B52">
        <label>52</label>
        <mixed-citation>52. Sarganas G, Schaffrath Rosario A, Niessner C, Woll A, Neuhauser HK. Tracking of Blood Pressure in Children and Adolescents in Germany in the Context of Risk Factors for Hypertension. Int J Hypertens. 2018;2018:8429891. doi: 10.1155/2018/8429891.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sarganas</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Schaffrath Rosario</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Niessner</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Woll</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Neuhauser</surname>
              <given-names>HK</given-names>
            </name>
          </person-group>
          <article-title>Tracking of Blood Pressure in Children and Adolescents in Germany in the Context of Risk Factors for Hypertension</article-title>
          <source> Int J Hypertens </source>
          <year>2018</year>
          <volume>2018</volume>
          <size units="pages">8429891</size>
          <issue-id pub-id-type="doi">10.1155/2018/8429891</issue-id>
        </element-citation>
      </ref>
      <ref id="B53">
        <label>53</label>
        <mixed-citation>53. Silveira JF, Reuter CP, Welser L, Pfeiffer KA, Andersen LB, Pohl HH, et al. Tracking of Cardiometabolic Risk in a Brazilian Schoolchildren Cohort: A 3-year Longitudinal Study. J Sports Med Phys Fitness. 2021;61(7):997-1006. doi: 10.23736/S0022-4707.20.11479-8.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Silveira</surname>
              <given-names>JF</given-names>
            </name>
            <name>
              <surname>Reuter</surname>
              <given-names>CP</given-names>
            </name>
            <name>
              <surname>Welser</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Pfeiffer</surname>
              <given-names>KA</given-names>
            </name>
            <name>
              <surname>Andersen</surname>
              <given-names>LB</given-names>
            </name>
            <name>
              <surname>Pohl</surname>
              <given-names>HH</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Tracking of Cardiometabolic Risk in a Brazilian Schoolchildren Cohort: A 3-year Longitudinal Study</article-title>
          <source> J Sports Med Phys Fitness </source>
          <year>2021</year>
          <volume>61</volume>
          <issue>7</issue>
          <fpage>997</fpage>
          <lpage>1006</lpage>
          <issue-id pub-id-type="doi">10.23736/S0022-4707.20.11479-8</issue-id>
        </element-citation>
      </ref>
      <ref id="B54">
        <label>54</label>
        <mixed-citation>54. International Diabetes Federation. IDF Diabetes Atlas. Brussels: IDF; 2015.</mixed-citation>
        <element-citation publication-type="report">
          <person-group person-group-type="author">
            <collab>International Diabetes Federation</collab>
          </person-group>
          <source> IDF Diabetes Atlas </source>
          <publisher-loc>Brussels</publisher-loc>
          <publisher-name>IDF</publisher-name>
          <year>2015</year>
        </element-citation>
      </ref>
      <ref id="B55">
        <label>55</label>
        <mixed-citation>55. Kapur G, Mattoo TK. Primary Hypertension in Children. In: Pediatric Hypertension. New York: Springer International Publishing; 2018. p. 405-29.</mixed-citation>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Kapur</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Mattoo</surname>
              <given-names>TK</given-names>
            </name>
          </person-group>
          <chapter-title>Primary Hypertension in Children</chapter-title>
          <source> Pediatric Hypertension </source>
          <publisher-loc>New York</publisher-loc>
          <publisher-name>Springer International Publishing</publisher-name>
          <year>2018</year>
          <fpage>405</fpage>
          <lpage>429</lpage>
        </element-citation>
      </ref>
    </ref-list>
    <fn-group>
      <fn fn-type="other">
        <p>Vincula&#231;&#227;o acad&#234;mica</p>
        <p>Este artigo &#233; parte da p&#243;s gradua&#231;&#227;o de Let&#237;cia Welser pelo Programa de P&#243;s-gradua&#231;&#227;o em Promo&#231;&#227;o da Sa&#250;de da Universidade de Santa Cruz do Sul.</p>
      </fn>
      <fn fn-type="other">
        <p>Aprova&#231;&#227;o &#233;tica e consentimento informado</p>
        <p>Este estudo foi aprovado pelo Comit&#234; de &#201;tica do Universidade de Santa Cruz do Sul sob o n&#250;mero de protocolo 2959/2011 e 714.216. Todos os procedimentos envolvidos nesse estudo est&#227;o de acordo com a Declara&#231;&#227;o de Helsinki de 1975, atualizada em 2013. O consentimento informado foi obtido de todos os participantes inclu&#237;dos no estudo.</p>
      </fn>
    </fn-group>
    <fn-group>
      <fn fn-type="financial-disclosure" id="fn6">
        <p>Fontes de financiamento: O presente estudo foi financiado pela CAPES &#8211; C&#243;digo de Financiamento 001. Edital FAPERGS/CAPES 06/2018 - Programa de Internacionaliza&#231;&#227;o da P&#243;s-Gradua&#231;&#227;o.</p>
      </fn>
    </fn-group>
  </back>
  <sub-article article-type="translation" id="TRen" xml:lang="en">
    <front-stub>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Original Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Incidence of Arterial Hypertension is Associated with Adiposity in Children and Adolescents</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">0000-0003-1134-2383</contrib-id>
          <name>
            <surname>Welser</surname>
            <given-names>Let&#237;cia</given-names>
          </name>
          <xref ref-type="aff" rid="aff1001">
            <sup>1</sup>
          </xref>
          <role>Conception and design of the research</role>
          <role>Acquisition of data</role>
          <role>Analysis and interpretation of the data and Writing of the manuscript</role>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Pfeiffer</surname>
            <given-names>Karin Allor</given-names>
          </name>
          <xref ref-type="aff" rid="aff2001">
            <sup>2</sup>
          </xref>
          <role>Critical revision of the manuscript for important intellectual content</role>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Silveira</surname>
            <given-names>Jo&#227;o Francisco de Castro</given-names>
          </name>
          <xref ref-type="aff" rid="aff3001">
            <sup>3</sup>
          </xref>
          <role>Acquisition of data</role>
          <role>Analysis and interpretation of the data and Writing of the manuscript</role>
          <role>Statistical analysis</role>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Valim</surname>
            <given-names>Andreia Rosane de Moura</given-names>
          </name>
          <role>Critical revision of the manuscript for important intellectual content</role>
          <xref ref-type="aff" rid="aff1001">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Renner</surname>
            <given-names>Jane Dagmar Pollo</given-names>
          </name>
          <role>Obtaining financing</role>
          <role>Critical revision of the manuscript for important intellectual content</role>
          <xref ref-type="aff" rid="aff1001">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Reuter</surname>
            <given-names>C&#233;zane Priscila</given-names>
          </name>
          <role>Conception and design of the research</role>
          <role>Acquisition of data</role>
          <role>Statistical analysis</role>
          <role>Obtaining financing</role>
          <role>Critical revision of the manuscript for important intellectual content</role>
          <xref ref-type="aff" rid="aff1001">
            <sup>1</sup>
          </xref>
        </contrib>
      </contrib-group>
      <aff id="aff1001">
        <label>1</label>
        <country country="BR">Brazil</country>
        <institution content-type="original">Universidade de Santa Cruz do Sul, Santa Cruz do Sul, RS &#8211; Brazil</institution>
      </aff>
      <aff id="aff2001">
        <label>2</label>
        <country country="US">USA</country>
        <institution content-type="original">Michigan State University, East Lansing, Michigan &#8211; USA</institution>
      </aff>
      <aff id="aff3001">
        <label>3</label>
        <country country="BR">Brazil</country>
        <institution content-type="original">Universidade Federal do Rio Grande do Sul, Porto Alegre, RS &#8211; Brazil</institution>
      </aff>
      <author-notes>
        <corresp id="c01001">Mailing Address: Let&#237;cia Welser &#8226; Universidade de Santa Cruz do Sul &#8211; Av. Independ&#234;ncia, 2293 Bloco 42, sala 4206. Postal Code 96815-900, Santa Cruz do Sul, RS &#8211; Brazil. E-mail: leticiawelser2017@gmail.com</corresp>
        <fn fn-type="conflict">
          <p>Potential conflict of interest</p>
          <p>No potential conflict of interest relevant to this article was reported.</p>
        </fn>
      </author-notes>
      <abstract>
        <title>Abstract</title>
        <sec>
          <title>Background</title>
          <p>The increase of hypertension in children and adolescents has attracted the attention of the scientific community largely due to its association with the obesity epidemic.</p>
        </sec>
        <sec>
          <title>Objectives</title>
          <p>To describe the incidence of hypertension and its relationship with the cardiometabolic and genetic profile in children and adolescents from a city in southern Brazil in a three-year period.</p>
        </sec>
        <sec>
          <title>Methods</title>
          <p>This longitudinal study followed 469 children and adolescents, aged 7-17 years old (43.1% boys), assessed at two-time points. We evaluated systolic and diastolic blood pressures (SBP and DBP), waist circumference (WC), body mass index (BMI), body fat percentage (%BF), lipid profile, glucose, cardiorespiratory fitness (CRF), and rs9939609 Polymorphism ( <italic>FTO</italic> ). Cumulative incidence of hypertension was calculated, and multinomial logistic regression was conducted. The statistical significance was established as p &lt; 0.05.</p>
        </sec>
        <sec>
          <title>Results</title>
          <p>After three years, the incidence of hypertension was 11.5%. Overweight or obese individuals were more likely to become borderline hypertensive (overweight OR: 3.22, 95% CI: 1.08-9.55; obesity OR: 4.05, 95% CI: 1.68-9.75), and obese individuals were more likely to become hypertensive (obesity OR: 4.84, 95% CI: 1.57-14.95). High-risk WC and %BF values were associated with hypertension development (OR: 3.41, 95% CI: 1.26-9.19; OR: 2.49, 95% CI: 1.08-5.75, respectively).</p>
        </sec>
        <sec>
          <title>Conclusions</title>
          <p>We found a higher incidence of hypertension in children and adolescents as compared with previous studies. Individuals with higher values of BMI, WC and %BF at baseline were more likely to develop hypertension, suggesting the importance of adiposity in the development of hypertension even in such a young population.</p>
        </sec>
      </abstract>
      <kwd-group xml:lang="en">
        <kwd>Cardiovascular Diseases</kwd>
        <kwd>Arterial Pressure</kwd>
        <kwd>Obesity</kwd>
      </kwd-group>
    </front-stub>
    <body>
      <sec sec-type="intro">
        <title>Introduction</title>
        <p>The increase over time in blood pressure levels in children and adolescents has attracted the attention of health professionals and the scientific community,<sup><xref rid="B1" ref-type="bibr">1</xref></sup>largely due to its association with the obesity epidemic.<sup><xref rid="B2" ref-type="bibr">2</xref></sup>According to a recent study,<sup><xref rid="B3" ref-type="bibr">3</xref></sup>it is estimated that the worldwide prevalence of hypertension is 4% in children and adolescents, and the prevalence of high blood pressure according to the new guidelines of the American Academy of Pediatrics is 15%. Although these prevalence estimates may have been underestimated before the recent reclassification,<sup><xref rid="B4" ref-type="bibr">4</xref></sup>data have indicated that the rates in developing countries are on the rise.<sup><xref rid="B5" ref-type="bibr">5</xref></sup></p>
        <p>Over the last few years more attention has been given to the relationship between hypertension and the development of end-organ damage emanating from early dysfunctions. The main modifiable risk factors to prevent strokes and other health issues are hypertension,<sup><xref rid="B6" ref-type="bibr">6</xref> , <xref rid="B7" ref-type="bibr">7</xref> </sup>diabetes mellitus, tobacco smoking, and hyperlipidemia, as well as poor diet/nutrition, physical inactivity, and obesity.<sup><xref rid="B8" ref-type="bibr">8</xref></sup>The strong association between obesity and hypertension prompted the development of several simple and low-cost measures to assess body adiposity, e.g., body mass index (BMI), waist circumference (WC) and body fat percentage (BF).<sup><xref rid="B9" ref-type="bibr">9</xref></sup>It is known that the risk of hypertension increases with the increase in obesity indexes, increasing the chances of cardiometabolic problems.<sup><xref rid="B10" ref-type="bibr">10</xref></sup>It is well documented in the literature that early risk factors during childhood can lead to cardiorespiratory complications in adolescence<sup><xref rid="B11" ref-type="bibr">11</xref></sup>and adulthood.<sup><xref rid="B12" ref-type="bibr">12</xref></sup></p>
        <p>Another important risk factor for hypertension is low levels of cardiorespiratory fitness (CRF). Data show that higher levels of CRF provide lower risk of hypertension.<sup><xref rid="B13" ref-type="bibr">13</xref></sup>Biochemical variables such as dyslipidemia,<sup><xref rid="B14" ref-type="bibr">14</xref></sup>hyperuricemia,<sup><xref rid="B15" ref-type="bibr">15</xref></sup>and altered levels of serum glucose (i.e., insulin resistance)<sup><xref rid="B16" ref-type="bibr">16</xref></sup>have shown to be important modifiable risk factors for hypertension, but CRF has an independent, predictive, and powerful negative association with blood pressure among children and adolescents.</p>
        <p>Although the prevalence of hypertension has been well documented in several studies, there are few studies regarding incidence of hypertension in the general population.<sup><xref rid="B17" ref-type="bibr">17</xref></sup>Studies addressing the incidence of high blood pressure and its relationship with other cardiometabolic variables, including genetic profile, in children and adolescents are even scarcer. Based on these considerations, the aim of this study is to describe the incidence of hypertension and its relationship with cardiometabolic (weight status, CRF and biochemical profile) variables and genotypes of the rs9939609 polymorphism of the FTO gene in Brazilian children and adolescents.</p>
      </sec>
      <sec sec-type="methods">
        <title>Methods</title>
        <p>The target population of this retrospective cohort research were volunteer children and adolescents of the city of Santa Cruz do Sul, in Rio Grande do Sul state, Brazil. All procedures were conducted at laboratories, rooms, and sports complex of the university campus, and consisted of assessment of CRF, anthropometry, laboratory data, and genetic polymorphism.</p>
        <p>Inclusion criteria for this subsample were students who: a) attended the 2011 assessment and returned in 2014; b) took part in the blood collection; c) underwent complete anthropometric assessment; d) filled out all the forms; and e) were in the range between seven and 17 years old in both assessments. In total, results of 469 students were analyzed, as are shown in <xref rid="f01001" ref-type="fig">Central Figure</xref> .</p>
        <p>
          <fig id="f01001">
            <label>Central Illustration</label>
            <caption>
              <title>: Incidence of Arterial Hypertension is Associated with Adiposity in Children and Adolescents</title>
            </caption>
            <graphic xlink:href="1678-4170-abc-120-02-e20220070-20070-gf01-en.tif"/></fig>
        </p>
        <p>The participants of this study were children and adolescents between 7-17 years old, of both sexes, from 19 public and private schools, stratified by regions (north, south, east, west and center), from urban and rural areas. The sample selected is from two databases, including only the students who attended the physical assessments in 2011/2012 (baseline) and returned in 2014/2015 (follow-up) ( <xref rid="f02001" ref-type="fig">Figure 1</xref> ). The databases come from a larger study named &#8220;Schoolchildren&#8217;s Health Study&#8221;, stratified by clusters. This research was approved by the Committee of Ethics in Research with Human Subjects of the University of Santa Cruz do Sul &#8211; UNISC (approval numbers 2959/2011 and 714.216 for baseline and follow-up, respectively). All parents or guardians were informed about the procedures and signed an informed consent form, authorizing the participation of the student in the study.</p>
        <p>
          <fig id="f02001">
            <label>Figure 1</label>
            <caption>
              <title>&#8211; Flowchart of study sample selection.</title>
            </caption>
            <graphic xlink:href="1678-4170-abc-120-02-e20220070-20070-gf02-en.tif"/></fig>
        </p>
        <p>The variables included in the present study were systolic blood pressure (SBP), diastolic blood pressure (DBP), WC, BMI, %BF, lipid profile (triglyceride [TG], total cholesterol [TC], high-density lipoprotein cholesterol [HDL-C], low-density lipoprotein cholesterol [LDL-C]), glucose, and CRF.</p>
        <p>SBP and DBP were measured twice with the student seated for at least five minutes in a quiet room. A sphygmomanometer and stethoscope were used on the right arm with an appropriate cuff for the arm circumference. SBP was determined by the first Korotkoff sound and DBP by the fifth Korotkoff sound, that is, when the sounds are no longer audible or when the timbre of the sound changes. These measurements were classified by the 90th and 95th percentiles for borderline and hypertension according to the Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents.<sup><xref rid="B18" ref-type="bibr">18</xref></sup></p>
        <p>WC was measured to the nearest 1mm using a non-elastic tape (Cardiomed&#174;). Measurement was taken at the narrowest part of the trunk between the ribs and the iliac crest. WC was classified as proposed by Fern&#225;ndez et al.;<sup><xref rid="B19" ref-type="bibr">19</xref></sup>abdominal obesity was defined as measures above the 75th percentile, according to sex and age. To calculate BMI, height was measured using a stadiometer coupled to the anthropometric scale (Filizola&#174;), which was used for weight assessment, measured for each participant in light clothing without shoes. The formula BMI = weight / height<sup><xref rid="B2" ref-type="bibr">2</xref></sup>(kg/m<sup><xref rid="B2" ref-type="bibr">2</xref></sup>) was used. The result was classified according to the WHO (2007)<sup><xref rid="B20" ref-type="bibr">20</xref></sup>percentile curves for age and sex. Participants with percentile &lt;3 were classified as underweight, percentile &#8805;85 as overweight and percentile &#8805; 97 as obese. To measure %BF, tricipital and subscapular skinfolds were measured using the Lange&#174; caliper (MultiMed, Skinfold Caliper, USA). The %BF calculation was performed using the Heyward and Stolarczyk<sup><xref rid="B21" ref-type="bibr">21</xref></sup>equation and classified as very low; low; ideal; moderately high; high; and very high according to Lohman.<sup><xref rid="B22" ref-type="bibr">22</xref></sup>The first three categories were reclassified as lower levels and the other categories as higher levels for analyses.</p>
        <p>For the lipid profile and glucose, 10mL of blood were collected from the brachial vein after a 12-hour fast; 5mL were placed in dry Vacutainer&#174; tubes for analysis of cardiometabolic parameters, and 5mL were placed in the EDTA Vacutainer&#174; tubes for further analysis. Levels of TC, HDL-C, LDL-C, TG, and glucose were evaluated in serum samples. The TC, HDL-C, LDL-C, and TG values were classified according to international reference values.<sup><xref rid="B23" ref-type="bibr">23</xref></sup>Participants were considered dyslipidemic if at least one of the parameters listed above was found to be altered. LDL-C was calculated using the Friedewald formula.<sup><xref rid="B24" ref-type="bibr">24</xref></sup>Blood glucose levels were determined at the Exercise Biochemistry Laboratory of the university using the automated equipment Miura One (I.S.E., Rome, Italy) and a DiaSys (DiaSys Diagnostic Systems, Germany) commercial kit, and classified according to the American Diabetes Association protocols:<sup><xref rid="B25" ref-type="bibr">25</xref></sup>normal, pre-diabetes and diabetes. For statistical purposes, the pre-diabetes and diabetes classes were grouped and considered as &#8220;high&#8221; glucose.</p>
        <p>For genetic polymorphism evaluation, the <italic>rs9939609 FTO</italic> (fat mass and obesity-associated gene) was assessed due to its association (A allele) with the presence of obesity in previous studies in Brazil.<sup><xref rid="B26" ref-type="bibr">26</xref></sup>Genotyping (alleles AA, AT, TT) was performed by real-time polymerase chain reaction (PCR), using TaqMan&#8482; probes as previously described.<sup><xref rid="B27" ref-type="bibr">27</xref></sup>The Hardy-Weinberg equilibrium was tested and confirmed (p&gt;0.05).</p>
        <p>CRF was assessed by indirect submaximal exercise tests. The 9-minute walk/run test was used at baseline, and the 6-minute walk/run test was used in the follow-up, according to the protocols of the Projeto Esporte Brasil (PROESP-BR).<sup><xref rid="B28" ref-type="bibr">28</xref> , <xref rid="B29" ref-type="bibr">29</xref> </sup>For both tests the children and adolescents were divided in groups that were adequate for the running track dimensions. They were instructed to run as long as possible, avoiding velocity peaks interspersed by long walks. During the test, the participants were verbally encouraged. At the end of the test, after a signal was given, the students stopped running and remained in place where they were standing until the distance traveled (in meters) was recorded. The result given in meters was classified as a categorical variable, dichotomized into &#8220;higher&#8221; and &#8220;lower&#8221; values according to the PROESP-BR test manual.<sup><xref rid="B30" ref-type="bibr">30</xref></sup></p>
        <sec>
          <title>Statistical analysis</title>
          <p>The data were analyzed with Statistical Package for the Social Sciences (SPSS) software, version 23.0 (IBM, Armonk, NY, USA). The characteristics of the sample were described in the two assessed periods, 2011/12 (baseline) and 2014/15 (follow-up), as absolute and percentage values by sex, age, rs9939609 Polymorphism ( <italic>FTO</italic> )and skin color/ethnicity. The cumulative incidence (new cases of hypertension) over three years was calculated.</p>
          <p>A multinomial logistic regression model was constructed, with hypertension as the dependent variable (normotensive was the reference category) and BMI, WC, %BF, glucose, dyslipidemia, rs9939609 Polymorphism ( <italic>FTO</italic> ) and CRF as the independent variables, with odds ratio (OR) and 95% confidence interval (CI) to indicate the odds of changing from normotensive to borderline or from normotensive to hypertensive. Three models were constructed, since adiposity measures are highly associated and should not be placed in the same model as independent variables: Model 1 with BMI, Model 2 with WC, and Model 3 with %BF, all adjusted for age, sex, and skin color. The level of statistical significance was established as p &lt; 0.05.</p>
        </sec>
      </sec>
      <sec sec-type="results">
        <title>Results</title>
        <p>Participants&#8217; characteristics of BMI, WC, %BF, glucose, dyslipidemia, and CRF are shown in <xref rid="t1001" ref-type="table">Table 1</xref> . Of the 469 children and adolescents evaluated, 202 (43.1%) were male, and 77.0% were white. Regarding the rs9939609 Polymorphism <italic>(FTO)</italic> 37.5% were classified as allele TT, 47.6% as AT and 14.9% as AA.</p>
        <p>
          <table-wrap id="t1001">
            <label>Table 1</label>
            <caption>
              <title>&#8211; Description of the participants&#8217; metabolic profile by year of assessment</title>
            </caption>
            <table frame="hsides" rules="groups">
              <colgroup width="33%">
                <col/>
                <col/>
                <col/>
              </colgroup>
              <thead>
                <tr>
                  <th align="left">Variables</th>
                  <th>n (%) Baseline</th>
                  <th>Follow-up</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td>
                    <bold>BMI</bold>
                  </td>
                  <td> </td>
                  <td> </td>
                </tr>
                <tr>
                  <td> Underweight</td>
                  <td align="center">6 (1.3)</td>
                  <td align="center">4 (0.9)</td>
                </tr>
                <tr>
                  <td> Normal</td>
                  <td align="center">283 (60.3)</td>
                  <td align="center">289 (61.6)</td>
                </tr>
                <tr>
                  <td> Overweight</td>
                  <td align="center">92 (19.6)</td>
                  <td align="center">90 (19.2)</td>
                </tr>
                <tr>
                  <td> Obesity</td>
                  <td align="center">88 (18.8)</td>
                  <td align="center">86 (18.3)</td>
                </tr>
                <tr>
                  <td>
                    <bold>WC</bold>
                  </td>
                  <td> </td>
                  <td> </td>
                </tr>
                <tr>
                  <td> Lower risk</td>
                  <td align="center">357 (76.1)</td>
                  <td align="center">366 (78.0)</td>
                </tr>
                <tr>
                  <td> Higher risk</td>
                  <td align="center">112 (23.9)</td>
                  <td align="center">103 (22.0)</td>
                </tr>
                <tr>
                  <td>
                    <bold>%BF</bold>
                  </td>
                  <td> </td>
                  <td> </td>
                </tr>
                <tr>
                  <td> Lower</td>
                  <td align="center">268 (57.1)</td>
                  <td align="center">297 (63.3)</td>
                </tr>
                <tr>
                  <td> Higher</td>
                  <td align="center">201 (42.9)</td>
                  <td align="center">172 (36.7)</td>
                </tr>
                <tr>
                  <td>
                    <bold>Glucose</bold>
                  </td>
                  <td> </td>
                  <td> </td>
                </tr>
                <tr>
                  <td> Normal</td>
                  <td align="center">356 (83.0)</td>
                  <td align="center">396 (85.5)</td>
                </tr>
                <tr>
                  <td> High</td>
                  <td align="center">73 (17.0)</td>
                  <td align="center">67 (14.5)</td>
                </tr>
                <tr>
                  <td>
                    <bold>Dyslipidemia</bold>
                  </td>
                  <td> </td>
                  <td> </td>
                </tr>
                <tr>
                  <td> No</td>
                  <td align="center">249 (54.8)</td>
                  <td align="center">249 (54.8)</td>
                </tr>
                <tr>
                  <td> Yes</td>
                  <td align="center">205 (45.2)</td>
                  <td align="center">205 (45.2)</td>
                </tr>
                <tr>
                  <td>
                    <bold>CRF</bold>
                  </td>
                  <td> </td>
                  <td> </td>
                </tr>
                <tr>
                  <td> Lower</td>
                  <td align="center">206 (43.9)</td>
                  <td align="center">261 (56.5)</td>
                </tr>
                <tr>
                  <td> Higher</td>
                  <td align="center">263 (56.1)</td>
                  <td align="center">201 (43.5)</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="TFN1001">
                <p>
                  <italic>BMI: body mass index; WC: waist circumference; %BF: percentage of body fat; CRF: cardiorespiratory fitness.</italic>
                </p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </p>
        <p><xref rid="t2001" ref-type="table">Table 2</xref> describes the incidence of altered blood pressure over three years. Most subjects remained classified as normotensive, while approximately one third of the normotensive sample had increases in their blood pressure levels (moving to the borderline/hypertensive categories). It should be noted that a fair number of borderline and hypertensive individuals became normotensive.</p>
        <p>
          <table-wrap id="t2001">
            <label>Table 2</label>
            <caption>
              <title>&#8211; Longitudinal comparison of participants according to blood pressure categories</title>
            </caption>
            <table frame="hsides" rules="groups">
              <colgroup width="50%">
                <col/>
                <col/>
              </colgroup>
              <thead>
                <tr>
                  <th align="left">Blood Pressure</th>
                  <th>n (%)</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td>Normotensive (maintaining)</td>
                  <td align="center">309 (65.9)</td>
                </tr>
                <tr>
                  <td>Normotensive to borderline</td>
                  <td align="center">60 (12.8)</td>
                </tr>
                <tr>
                  <td>Normotensive to hypertensive</td>
                  <td align="center">54 (11.5)</td>
                </tr>
                <tr>
                  <td>Borderline (maintaining)</td>
                  <td align="center">2 (0.4)</td>
                </tr>
                <tr>
                  <td>Borderline to normotensive</td>
                  <td align="center">6 (1.3)</td>
                </tr>
                <tr>
                  <td>Borderline to hypertensive</td>
                  <td align="center">6 (1.3)</td>
                </tr>
                <tr>
                  <td>Hypertensive (maintaining)</td>
                  <td align="center">9 (1.9)</td>
                </tr>
                <tr>
                  <td>Hypertensive to normotensive</td>
                  <td align="center">15 (3.2)</td>
                </tr>
                <tr>
                  <td>Hypertensive to borderline</td>
                  <td align="center">8 (1.7)</td>
                </tr>
              </tbody>
            </table>
          </table-wrap>
        </p>
        <p><xref rid="f03001" ref-type="fig">Figures 2</xref> and <xref rid="f04001" ref-type="fig">3</xref> show the changes in ratings of PAS and PAD over time.</p>
        <p>
          <fig id="f03001">
            <label>Figure 2</label>
            <caption>
              <title>&#8211; Changes in the incidence of systolic blood pressure over three years.</title>
            </caption>
            <graphic xlink:href="1678-4170-abc-120-02-e20220070-20070-gf03-en.tif"/></fig>
        </p>
        <p>
          <fig id="f04001">
            <label>Figure 3</label>
            <caption>
              <title>&#8211; Changes in the incidence of diastolic blood pressure over three years.</title>
            </caption>
            <graphic xlink:href="1678-4170-abc-120-02-e20220070-20070-gf04-en.tif"/></fig>
        </p>
        <p><xref rid="t3001" ref-type="table">Table 3</xref> shows the odds of hypertension by adiposity parameters (BMI, WC, and %BF) and biochemical data, genotype, and CRF level. Children and adolescents who were overweight and obese according to baseline BMI were more likely to become borderline or hypertensive over three years. Increased WC values were associated with a high risk for hypertension, and increased %BF was associated with changes in blood pressure category, from normotensive to borderline, and from normotensive to hypertensive over the study period.</p>
        <p>
          <table-wrap id="t3001">
            <label>Table 3</label>
            <caption>
              <title>&#8211; Factors associated with changes of blood pressure classification over three years of follow-up</title>
            </caption>
            <table frame="hsides" rules="groups">
              <colgroup width="20%">
                <col/>
                <col/>
                <col/>
                <col/>
                <col/>
              </colgroup>
              <thead>
                <tr>
                  <th align="left" style="font-weight:normal"> </th>
                  <th colspan="4">Blood pressure modification across 3 years</th>
                </tr>
                <tr>
                  <th align="left">Baseline</th>
                  <th colspan="2">Normotensive &#61672; Borderline</th>
                  <th colspan="2">Normotensive &#61672; Hypertensive</th>
                </tr>
                <tr>
                  <th align="left" style="font-weight:normal"> </th>
                  <th>OR (95% CI)</th>
                  <th>p</th>
                  <th>OR (95% CI)</th>
                  <th>p</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td>
                    <bold>Model 1: BMI</bold>
                  </td>
                  <td> </td>
                  <td> </td>
                  <td> </td>
                  <td> </td>
                </tr>
                <tr>
                  <td>BMI</td>
                  <td> </td>
                  <td> </td>
                  <td> </td>
                  <td> </td>
                </tr>
                <tr>
                  <td> Underweight/Normal weight</td>
                  <td align="center">1</td>
                  <td> </td>
                  <td align="center">1</td>
                  <td> </td>
                </tr>
                <tr>
                  <td> Overweight</td>
                  <td align="center">3.22 (1.08-9.55)</td>
                  <td align="center">0.035</td>
                  <td align="center">1.69 (0.58-4.90)</td>
                  <td align="center">0.336</td>
                </tr>
                <tr>
                  <td> Obesity</td>
                  <td align="center">4.05 (1.68-9.75)</td>
                  <td align="center">0.002</td>
                  <td align="center">4.84 (1.57-14.95)</td>
                  <td align="center">0.006</td>
                </tr>
                <tr>
                  <td>Dyslipidemia</td>
                  <td> </td>
                  <td> </td>
                  <td> </td>
                  <td> </td>
                </tr>
                <tr>
                  <td> No</td>
                  <td align="center">1</td>
                  <td> </td>
                  <td align="center">1</td>
                  <td> </td>
                </tr>
                <tr>
                  <td> Yes</td>
                  <td align="center">0.86 (0.40-1.84)</td>
                  <td align="center">0.695</td>
                  <td align="center">1.60 (0.714-3.61)</td>
                  <td align="center">0.252</td>
                </tr>
                <tr>
                  <td>Glucose</td>
                  <td> </td>
                  <td> </td>
                  <td> </td>
                  <td> </td>
                </tr>
                <tr>
                  <td> Normal</td>
                  <td align="center">1</td>
                  <td> </td>
                  <td align="center">1</td>
                  <td> </td>
                </tr>
                <tr>
                  <td> High</td>
                  <td align="center">1.54 (0.60-3.96)</td>
                  <td align="center">0.370</td>
                  <td align="center">1.94 (0.74-5.07)</td>
                  <td align="center">0.177</td>
                </tr>
                <tr>
                  <td><italic>FTO</italic> rs9939609</td>
                  <td> </td>
                  <td> </td>
                  <td> </td>
                  <td> </td>
                </tr>
                <tr>
                  <td> TT</td>
                  <td align="center">1</td>
                  <td> </td>
                  <td align="center">1</td>
                  <td> </td>
                </tr>
                <tr>
                  <td> AT</td>
                  <td align="center">1.15 (0.482.74)</td>
                  <td align="center">0.750</td>
                  <td align="center">0.84 (0.36-1.97)</td>
                  <td align="center">0.686</td>
                </tr>
                <tr>
                  <td> AA</td>
                  <td align="center">1.68 (0.59-4.77)</td>
                  <td align="center">0.332</td>
                  <td align="center">0.58 (0.15-2.26)</td>
                  <td align="center">0.433</td>
                </tr>
                <tr>
                  <td>CRF</td>
                  <td> </td>
                  <td> </td>
                  <td> </td>
                  <td> </td>
                </tr>
                <tr>
                  <td> Higher</td>
                  <td align="center">1</td>
                  <td> </td>
                  <td align="center">1</td>
                  <td> </td>
                </tr>
                <tr>
                  <td> Lower</td>
                  <td align="center">1.60 (0.73-3.51)</td>
                  <td align="center">0.244</td>
                  <td align="center">1.19 (0.51-2.81)</td>
                  <td align="center">0.683</td>
                </tr>
                <tr>
                  <td>
                    <bold>Model 2: WC</bold>
                  </td>
                  <td> </td>
                  <td> </td>
                  <td> </td>
                  <td> </td>
                </tr>
                <tr>
                  <td>WC</td>
                  <td> </td>
                  <td> </td>
                  <td> </td>
                  <td> </td>
                </tr>
                <tr>
                  <td> Low risk</td>
                  <td align="center">1</td>
                  <td> </td>
                  <td align="center">1</td>
                  <td> </td>
                </tr>
                <tr>
                  <td> High risk</td>
                  <td align="center">2.46 (0.99-6.12)</td>
                  <td align="center">0.052</td>
                  <td align="center">3.41 (1.26-9.19)</td>
                  <td align="center">0.016</td>
                </tr>
                <tr>
                  <td>Dyslipidemia</td>
                  <td> </td>
                  <td> </td>
                  <td> </td>
                  <td> </td>
                </tr>
                <tr>
                  <td> No</td>
                  <td align="center">1</td>
                  <td> </td>
                  <td align="center">1</td>
                  <td> </td>
                </tr>
                <tr>
                  <td> Yes</td>
                  <td align="center">0.95 (0.45-2.01)</td>
                  <td align="center">0.898</td>
                  <td align="center">1.65 (0.74-3.70)</td>
                  <td align="center">0.224</td>
                </tr>
                <tr>
                  <td>Glucose</td>
                  <td> </td>
                  <td> </td>
                  <td> </td>
                  <td> </td>
                </tr>
                <tr>
                  <td> Normal</td>
                  <td align="center">1</td>
                  <td> </td>
                  <td align="center">1</td>
                  <td> </td>
                </tr>
                <tr>
                  <td> High</td>
                  <td align="center">1.78 (0.70-4.49)</td>
                  <td align="center">0.225</td>
                  <td align="center">1.92 (0.74-5.01)</td>
                  <td align="center">0.179</td>
                </tr>
                <tr>
                  <td><italic>FTO</italic> rs9939609</td>
                  <td> </td>
                  <td> </td>
                  <td> </td>
                  <td> </td>
                </tr>
                <tr>
                  <td> TT</td>
                  <td align="center">1</td>
                  <td> </td>
                  <td align="center">1</td>
                  <td> </td>
                </tr>
                <tr>
                  <td> AT</td>
                  <td align="center">1.05 (0.45-2.47)</td>
                  <td align="center">0.902</td>
                  <td> </td>
                  <td> </td>
                </tr>
                <tr>
                  <td> AA</td>
                  <td align="center">1.57 (0.56-4.38)</td>
                  <td align="center">0.387</td>
                  <td align="center">0.53 (0.14-2.06)</td>
                  <td align="center">0.363</td>
                </tr>
                <tr>
                  <td>CRF</td>
                  <td> </td>
                  <td> </td>
                  <td> </td>
                  <td> </td>
                </tr>
                <tr>
                  <td> Higher</td>
                  <td align="center">1</td>
                  <td> </td>
                  <td align="center">1</td>
                  <td> </td>
                </tr>
                <tr>
                  <td> Lower</td>
                  <td align="center">1.65 (0.76-3.59)</td>
                  <td align="center">0.204</td>
                  <td align="center">1.34 (0.58-3.09)</td>
                  <td align="center">0.489</td>
                </tr>
                <tr>
                  <td>
                    <bold>Model 3: %BF</bold>
                  </td>
                  <td> </td>
                  <td> </td>
                  <td> </td>
                  <td> </td>
                </tr>
                <tr>
                  <td>%BF</td>
                  <td> </td>
                  <td> </td>
                  <td> </td>
                  <td> </td>
                </tr>
                <tr>
                  <td> Lower</td>
                  <td align="center">1</td>
                  <td> </td>
                  <td align="center">1</td>
                  <td> </td>
                </tr>
                <tr>
                  <td> Higher</td>
                  <td align="center">2.28 (1.04-4.97)</td>
                  <td align="center">0.039</td>
                  <td align="center">2.49 (1.08-5.75)</td>
                  <td align="center">0.033</td>
                </tr>
                <tr>
                  <td>Dyslipidemia</td>
                  <td> </td>
                  <td> </td>
                  <td> </td>
                  <td> </td>
                </tr>
                <tr>
                  <td> No</td>
                  <td align="center">1</td>
                  <td> </td>
                  <td align="center">1</td>
                  <td> </td>
                </tr>
                <tr>
                  <td> Yes</td>
                  <td align="center">0.93 (0.44-1.96)</td>
                  <td align="center">0.845</td>
                  <td align="center">1.58 (0.71-3.52)</td>
                  <td align="center">0.265</td>
                </tr>
                <tr>
                  <td>Glucose</td>
                  <td> </td>
                  <td> </td>
                  <td> </td>
                  <td> </td>
                </tr>
                <tr>
                  <td> Normal</td>
                  <td align="center">1</td>
                  <td> </td>
                  <td align="center">1</td>
                  <td> </td>
                </tr>
                <tr>
                  <td> High</td>
                  <td align="center">1.59 (0.63-4.01)</td>
                  <td align="center">0.327</td>
                  <td align="center">1.68 (0.65-4.34)</td>
                  <td align="center">0.280</td>
                </tr>
                <tr>
                  <td><italic>FTO</italic> rs9939609</td>
                  <td> </td>
                  <td> </td>
                  <td> </td>
                  <td> </td>
                </tr>
                <tr>
                  <td> TT</td>
                  <td align="center">1</td>
                  <td> </td>
                  <td align="center">1</td>
                  <td> </td>
                </tr>
                <tr>
                  <td> AT</td>
                  <td align="center">1.12 (0.48-2.61)</td>
                  <td align="center">0.799</td>
                  <td align="center">0.90 (0.39-2.09)</td>
                  <td align="center">0.807</td>
                </tr>
                <tr>
                  <td> AA</td>
                  <td align="center">1.74 (0.62-4.85)</td>
                  <td align="center">0.292</td>
                  <td align="center">0.57 (0.15-2.21)</td>
                  <td align="center">0.419</td>
                </tr>
                <tr>
                  <td>CRF</td>
                  <td> </td>
                  <td> </td>
                  <td> </td>
                  <td> </td>
                </tr>
                <tr>
                  <td> Higher</td>
                  <td align="center">1</td>
                  <td> </td>
                  <td align="center">1</td>
                  <td> </td>
                </tr>
                <tr>
                  <td> Lower</td>
                  <td align="center">1.61 (0.74-3.49)</td>
                  <td align="center">0.229</td>
                  <td align="center">1.35 (0.59-3.08)</td>
                  <td align="center">0.479</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="TFN2001">
                <p>
                  <italic>BMI: body mass index; WC: waist circumference; %BF: percentual of body fat; CRF: cardiorespiratory fitness</italic>
                </p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </p>
      </sec>
      <sec sec-type="discussion">
        <title>Discussion</title>
        <p>The aim of this study was to determine the incidence of hypertension and to relate it with cardiometabolic variables (weight status, CRF, and biochemical profile) and rs9939609 Polymorphism ( <italic>FTO</italic> ) of Brazilian children and adolescents. Our results identified 12.8% of normotensive subjects at baseline who became borderline, and 11.5% of them changed to hypertensive. Importantly, all these associations were independent of growth and development. Furthermore, regarding the adiposity variables, children and adolescents who were overweight or obese according to BMI (model 1) at baseline were more likely to become borderline, while those who were obese were more likely to become hypertensive over three years. High-risk values for WC (model 2) were associated with hypertension, and higher %BF values (model 3) were associated with the development of both borderline hypertension and hypertension.</p>
        <p>The incidence of high blood pressure levels has been rising in children and adolescents.<sup><xref rid="B4" ref-type="bibr">4</xref></sup>This increase is believed to be due to the high incidence of overweight and obesity in this population, since excess weight gain, especially when associated with increased visceral adiposity, is a major cause of hypertension.<sup><xref rid="B31" ref-type="bibr">31</xref></sup>According to a large study including Brazilian adolescents, the highest prevalence of hypertension in Brazil are in the south region, the same population assessed in the present study. The south region of Brazil also has the highest prevalence of overweight and obesity and the most physically inactive population.<sup><xref rid="B32" ref-type="bibr">32</xref></sup></p>
        <p>Our study demonstrated that children and adolescents who were overweight and obese according to BMI (model 1) at baseline were more likely to become borderline (overweight OR: 3.22, 95% CI: 1.08-9.55; obesity OR: 4.05, 95% CI: 1.68-9.75) or hypertensive (obesity OR: 4.84, 95% CI: 1.57-14.95) over three years. In addition, other studies with same-age populations have shown associations between BMI and elevated rates of blood pressure.<sup><xref rid="B33" ref-type="bibr">33</xref></sup>A similar but cross-sectional study<sup><xref rid="B34" ref-type="bibr">34</xref></sup>aimed to verify the association between overweight/obesity and high blood pressure in Brazilian students aged between six and 10 years old. Obesity increased by twice the chance of high blood pressure among children aged 6-7 years old. In children aged 8-9 years old, overweight doubled the chance of high blood pressure, while obesity quadrupled that chance.<sup><xref rid="B34" ref-type="bibr">34</xref></sup>In another study,<sup><xref rid="B35" ref-type="bibr">35</xref></sup>conducted with Chinese children and adolescents aged between 7 and 18 years old, a high prevalence of high blood pressure was also found among those who had overweight (19%) and obesity (23.2%).<sup><xref rid="B35" ref-type="bibr">35</xref></sup></p>
        <p>In our results (model 2), &#8220;high-risk&#8221; WC classification was associated with the development of hypertension at follow-up (OR: 3.41, 95% CI: 1.26-9.19), which is supported by several studies.<sup><xref rid="B36" ref-type="bibr">36</xref> - <xref rid="B39" ref-type="bibr">39</xref> </sup>There are findings that both WC and BMI were good predictors of elevated levels of blood pressure in every phase of life,<sup><xref rid="B2" ref-type="bibr">2</xref></sup>including one study that showed that WC was a good predictor of hypertension, even when the BMI was normal.<sup><xref rid="B40" ref-type="bibr">40</xref></sup>Another study, however, showed that high BMI, but not WC or %BF, was associated with high risk of hypertension in normal-weight Chinese children.<sup><xref rid="B41" ref-type="bibr">41</xref></sup>As it is known, abnormal distribution or excess of fat tissue impacts the renin-angiotensin-aldosterone system and the rise in production of non-esterified fatty acids and inflammatory cytokines (e.g., interleukin 6). Also, obesity is associated with a hyperinsulinemic state, which activates the sympathetic nervous system. These changes involve an increase in renal sodium reabsorption and intravascular volume, and vasoconstriction, which ultimately result in arterial hypertension.<sup><xref rid="B42" ref-type="bibr">42</xref></sup></p>
        <p>A systematic review of abdominal adiposity and cardiometabolic risk factors showed that blood pressure measurement was the most common cardiometabolic parameter among the studies.<sup><xref rid="B43" ref-type="bibr">43</xref></sup>Importantly, most of these studies confirmed the association between elevated levels of blood pressure and abdominal obesity; however, most were cross-sectional. On the other hand, some studies did not support WC as a better predictor than BMI to identify children with elevated levels of blood pressure.<sup><xref rid="B44" ref-type="bibr">44</xref></sup>A metanalysis included 23 longitudinal observation studies and found that WC and BMI were good predictors of diabetes but not hypertension.<sup><xref rid="B45" ref-type="bibr">45</xref></sup></p>
        <p>Also, children and adolescents with higher levels of %BF at baseline were more likely of becoming borderline (OR: 2.28, 95% CI: 1.04-4.97) or hypertensive (OR: 2.49, 95% CI: 1.08-5.75), corroborating some findings in the literature.<sup><xref rid="B46" ref-type="bibr">46</xref> , <xref rid="B47" ref-type="bibr">47</xref> </sup>A higher percentage of body fat could increase the risk of hypertension, and its reduction would be beneficial for the prevention and control of hypertension in children as shown by Tao et al.<sup><xref rid="B47" ref-type="bibr">47</xref></sup>In their study<sup><xref rid="B47" ref-type="bibr">47</xref></sup>and in the current study, all results related to adiposity point in the same direction: an association with high blood pressure. A study<sup><xref rid="B48" ref-type="bibr">48</xref></sup>in an adult population showed that weight loss had beneficial effects on incident hypertension and cardiovascular events. It is recognized that lifestyle changes have an impact on blood pressure levels and reinforce that weight reduction is an important goal for the primary prevention of cardiovascular events.<sup><xref rid="B48" ref-type="bibr">48</xref></sup>A 5% reduction of total body weight is associated with decrease of 20-30% in blood pressure levels<sup><xref rid="B49" ref-type="bibr">49</xref></sup>which is an important index of vascular function improvement.<sup><xref rid="B50" ref-type="bibr">50</xref></sup>Also, another study supported the association between blood pressure levels and obesity suggesting that high blood pressure might be more related to body composition rather than body weight itself, since in some situations body weight, and consequently BMI is high, but the %BF is low. The findings of the same study still suggest that losing or gaining weight, which changes the anthropometric profile, has a substantial impact on the reversal or development of hypertension, respectively.<sup><xref rid="B51" ref-type="bibr">51</xref></sup></p>
        <p>A tracking study indicated that blood pressure shows a moderate stability from childhood into adolescence or early adulthood, since blood pressure measurements seem to be a strong independent predictor for future measurements.<sup><xref rid="B52" ref-type="bibr">52</xref></sup>Another tracking study, this time including participants from late childhood to early adolescence, showed low-to-moderate stability to SBP and DBP over three years.<sup><xref rid="B53" ref-type="bibr">53</xref></sup>This trend may be explained by changes in the anthropometric profile over time<sup><xref rid="B49" ref-type="bibr">49</xref></sup>such as increase of central adiposity, the main risk factor for metabolic syndrome,<sup><xref rid="B54" ref-type="bibr">54</xref></sup>which can trigger changes alterations in blood pressure, blood lipids and glucose.<sup><xref rid="B50" ref-type="bibr">50</xref></sup>In the current study, there were also cases of patients who that changed from borderline or hypertension down to the normotensive category. One possible explanation is the influence of school, in which individuals participate in physical activities that can improve their physical status and consequently their health.</p>
        <p>None of the other risk factors showed a statistically significant association with borderline or hypertension in any of the models, perhaps because it is too early in life to show some consequence in health. Even though CRF and body composition are highly related, and CRF has shown to be an important modifiable risk factor for hypertension, and independent and powerful negative predictor of blood pressure among children and adolescents,<sup><xref rid="B16" ref-type="bibr">16</xref></sup>we found no statistically significant association between them. Therefore, the prevention of cardiovascular disease should begin during childhood through regular screening for hypertension, counseling for a healthy lifestyle, and prevention of modifiable risk factors as BMI, WC, and %BF.<sup><xref rid="B55" ref-type="bibr">55</xref></sup></p>
        <p>The present study has some limitations: our analyses did not control for physical activity, maturation stage, and dietary behaviors; BMI was used as an adiposity marker, even though there are more direct methods for assessing adiposity. Also, blood pressure was measured only twice in each assessment period, despite recommendations<sup><xref rid="B18" ref-type="bibr">18</xref></sup>for three measurements at each assessment. However, our study was comparable to most epidemiological studies which, for logistical and cost reasons, take single measurements at each assessment period. As strengths, this longitudinal study used a randomly selected sample at baseline to measure blood pressure, using the auscultatory method, by the same evaluator in both periods and according to the same recommendations.<sup><xref rid="B18" ref-type="bibr">18</xref></sup></p>
      </sec>
      <sec sec-type="conclusions">
        <title>Conclusion</title>
        <p>This longitudinal study showed that there is an increase in the number of new cases, represented by a high incidence of hypertension in children and adolescents, compared to previous studies. Additionally, our findings showed that children and adolescents with higher BMI, WC, or %BF at baseline were more likely to develop hypertension throughout the three years, highlighting the importance of pediatric health care to avoid future harm.</p>
      </sec>
    </body>
    <back>
      <ack>
        <title>Acknowledgments</title>
        <p>We thank all of the participants for their contributions to the research as well as all the support of the University of Santa Cruz do Sul &#8211; UNISC and the Coordination for the Improvement of Higher Education Personnel (CAPES) in Brazil.</p>
      </ack>
      <fn-group>
        <fn fn-type="other">
          <p>Study association</p>
          <p>This article is part of the thesis of post-graduation submitted by Let&#237;cia Welser, from Program of Health Promotion of Santa Cruz do Sul University.</p>
        </fn>
        <fn fn-type="other">
          <p>Ethics approval and consent to participate</p>
          <p>This study was approved by the Ethics Committee of the Universidade de Santa Cruz do Sul under the protocol number 2959/2011 e 714.216. All the procedures in this study were in accordance with the 1975 Helsinki Declaration, updated in 2013. Informed consent was obtained from all participants included in the study.</p>
        </fn>
      </fn-group>
      <fn-group>
        <fn fn-type="financial-disclosure" id="fn6001">
          <p>Sources of funding: This study was partially funded by CAPES &#8211; Funding Code 001. Edital FAPERGS/CAPES 06/2018 - Programa de Internacionaliza&#231;&#227;o da P&#243;s-Gradua&#231;&#227;o.</p>
        </fn>
      </fn-group>
    </back>
  </sub-article>
</article>
